{"items": "69", "sentiment_score_definition": "x <= -0.35: Bearish; -0.35 < x <= -0.15: Somewhat-Bearish; -0.15 < x < 0.15: Neutral; 0.15 <= x < 0.35: Somewhat_Bullish; x >= 0.35: Bullish", "relevance_score_definition": "0 < x <= 1, with a higher score indicating higher relevance.", "feed": [{"title": "CBD-Based Drug Reduces Pericarditis Pain And Inflammation, Shows New Clinical Study - Cardiol Therapeutics  ( NASDAQ:CRDL ) ", "url": "https://www.benzinga.com/markets/cannabis/24/11/42072269/cbd-based-drug-reduces-pericarditis-pain-and-inflammation-shows-new-clinical-study", "time_published": "20241119T192447", "authors": ["Nina Zdinjak"], "summary": "Cardiol Therapeutics Inc. CRDL, a clinical-stage life sciences company, reported results from its Phase II open-label MAvERIC-Pilot study of CardiolRx, a cannabidiol-based therapy for treating symptomatic recurrent pericarditis. Cannabidiol ( CBD ) is a non-psychoactive compound found in the ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/11/19/Doctor-Explaining-Heart-To-Elderly-Patie.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.144019, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CRDL", "relevance_score": "0.186738", "ticker_sentiment_score": "0.035418", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSTK", "relevance_score": "0.062761", "ticker_sentiment_score": "0.29461", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index - Cardiol Therapeutics  ( NASDAQ:CRDL ) ", "url": "https://www.benzinga.com/pressreleases/24/11/g41937017/cardiol-therapeutics-inc-added-to-prism-emerging-biotech-index", "time_published": "20241113T130000", "authors": ["Globe Newswire"], "summary": "NEW YORK, Nov. 13, 2024 ( GLOBE NEWSWIRE ) -- PRISM MarketView, a leading provider of market insights and company news, proudly announces that Cardiol Therapeutics Inc. CRDLCRDL has been added to the PRISM Emerging Biotech Index, which spotlights companies leading innovation and creating market ...", "banner_image": "https://ml.globenewswire.com/media/0f47e523-851a-4391-ae35-d2b8455812ba/small/pmv-main-logo-png.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.126119, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CRDL", "relevance_score": "0.33628", "ticker_sentiment_score": "0.399882", "ticker_sentiment_label": "Bullish"}]}, {"title": "Are Medical Stocks Lagging Cardiol Therapeutics  ( CRDL )  This Year?", "url": "https://www.zacks.com/stock/news/2354750/are-medical-stocks-lagging-cardiol-therapeutics-crdl-this-year", "time_published": "20241022T134013", "authors": ["Zacks Equity Research"], "summary": "Here is how Cardiol Therapeutics Inc. (CRDL) and Catalent (CTLT) have performed compared to their sector so far this year.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default76.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Earnings", "relevance_score": "0.714479"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.289351, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CRDL", "relevance_score": "0.769861", "ticker_sentiment_score": "0.430136", "ticker_sentiment_label": "Bullish"}, {"ticker": "CTLT", "relevance_score": "0.406197", "ticker_sentiment_score": "0.166796", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Why Cardiol Therapeutics  ( CRDL )  Stock Is Down 20% Today - Cardiol Therapeutics  ( NASDAQ:CRDL ) ", "url": "https://www.benzinga.com/news/24/10/41252681/why-cardiol-therapeutics-crdl-stock-is-down-20-today", "time_published": "20241009T144156", "authors": ["Henry Khederian"], "summary": "Cardiol Therapeutics Inc CRDL shares are trading lower by 18.4% to $1.60 Wednesday morning after the company announced a $13.5 million public offering of 8,437,500 common shares priced at $1.60 per unit.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/10/09/25.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.413559"}], "overall_sentiment_score": 0.31297, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CCORF", "relevance_score": "0.12546", "ticker_sentiment_score": "0.148047", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDL", "relevance_score": "0.570165", "ticker_sentiment_score": "0.207872", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "AZZ, Helen of Troy And 3 Stocks To Watch Heading Into Wednesday - AZZ  ( NYSE:AZZ ) ", "url": "https://www.benzinga.com/news/earnings/24/10/41244127/azz-helen-of-troy-and-3-stocks-to-watch-heading-into-wednesday", "time_published": "20241009T064921", "authors": ["Avi Kapoor"], "summary": "With U.S. stock futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Helen of Troy Limited HELE to report quarterly earnings at $1.04 per share on revenue of $458.24 million before the opening bell, according to ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/10/09/Stocks-Watch--Shutterstock.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.998356"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.998645"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.372503, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "CRDL", "relevance_score": "0.386875", "ticker_sentiment_score": "0.160894", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AZZ", "relevance_score": "0.386875", "ticker_sentiment_score": "0.441607", "ticker_sentiment_label": "Bullish"}, {"ticker": "ETWO", "relevance_score": "0.263942", "ticker_sentiment_score": "0.375577", "ticker_sentiment_label": "Bullish"}, {"ticker": "HELE", "relevance_score": "0.386875", "ticker_sentiment_score": "0.412319", "ticker_sentiment_label": "Bullish"}]}, {"title": "Cardiol Therapeutics  ( CRDL )  Upgraded to Buy: Here's Why", "url": "https://www.zacks.com/stock/news/2336037/cardiol-therapeutics-crdl-upgraded-to-buy-heres-why", "time_published": "20240913T160011", "authors": ["Zacks Equity Research"], "summary": "Cardiol Therapeutics (CRDL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default288.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.997845"}, {"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.692272"}], "overall_sentiment_score": 0.309572, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CRDL", "relevance_score": "0.363388", "ticker_sentiment_score": "0.325056", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Top 5 NASDAQ Biotech Stocks", "url": "https://investingnews.com/daily/life-science-investing/biotech-investing/top-nasdaq-biotech-stocks/", "time_published": "20240710T211500", "authors": ["Melissa Pistilli"], "summary": "After dropping to a low of 3,637.05 in October 2023, the index climbed to start 2024 at 4,457.02. It did hit a bump in the road early in Q2 when it plunged to 4,056.3 in April, but it quickly recovered and has since tracked even higher, reaching 4,634.21 on June 24.", "banner_image": "https://investingnews.com/media-library/row-of-test-tubes-and-pipette-with-chemical-droplet-chemical-coming-from-it.jpg?id=32361330&width=1200&height=800&quality=80&coordinates=0%2C1%2C0%2C1", "source": "Investing News Network", "category_within_source": "n/a", "source_domain": "investingnews.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.929393"}], "overall_sentiment_score": 0.161204, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CRDL", "relevance_score": "0.035714", "ticker_sentiment_score": "0.007001", "ticker_sentiment_label": "Neutral"}, {"ticker": "CADL", "relevance_score": "0.035714", "ticker_sentiment_score": "0.105262", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELYM", "relevance_score": "0.035714", "ticker_sentiment_score": "0.019337", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNTC", "relevance_score": "0.035714", "ticker_sentiment_score": "-0.091127", "ticker_sentiment_label": "Neutral"}]}, {"title": "5 Small Drug Stocks to Buy From a Recovering Industry", "url": "https://www.zacks.com/commentary/2278351/5-small-drug-stocks-to-buy-from-a-recovering-industry", "time_published": "20240524T125900", "authors": ["Kinjel Shah"], "summary": "Innovation is expected to continue to drive the growth of the Zacks Medical-Drugs industry. HRTX, BVS, AQST, ACRV and CRDL may prove to be good additions to one's portfolio.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/52/873.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.999897"}, {"topic": "Earnings", "relevance_score": "0.714479"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.451494"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.198595, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACRV", "relevance_score": "0.11392", "ticker_sentiment_score": "0.105003", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDL", "relevance_score": "0.091248", "ticker_sentiment_score": "0.097535", "ticker_sentiment_label": "Neutral"}, {"ticker": "BVS", "relevance_score": "0.091248", "ticker_sentiment_score": "0.097535", "ticker_sentiment_label": "Neutral"}, {"ticker": "AQST", "relevance_score": "0.091248", "ticker_sentiment_score": "0.097535", "ticker_sentiment_label": "Neutral"}, {"ticker": "HRTX", "relevance_score": "0.091248", "ticker_sentiment_score": "0.097535", "ticker_sentiment_label": "Neutral"}]}, {"title": "Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In - Corbus Pharmaceuticals  ( NASDAQ:CRBP ) , AbbVie  ( NYSE:ABBV ) ", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/05/38803783/will-pharma-and-healthcare-have-competitive-edge-in-cannabis-post-rescheduling-data", "time_published": "20240514T173240", "authors": ["Nicol\u00e1s Jose Rodriguez"], "summary": "Roy Bingham, CEO of BDSA, anticipates substantial growth in the U.S. cannabis market, projecting sales to reach nearly $46 billion by 2028. This growth would be primarily fueled by the expansion of adult-use markets and adoption of new licensed and regulated markets, both medical and recreational.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/05/13/dalle_2024-05-13_18.59.57_-_.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.929393"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.248127, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CRBP", "relevance_score": "0.088964", "ticker_sentiment_score": "-0.01174", "ticker_sentiment_label": "Neutral"}, {"ticker": "JAZZ", "relevance_score": "0.088964", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDL", "relevance_score": "0.088964", "ticker_sentiment_score": "0.287303", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ABBV", "relevance_score": "0.088964", "ticker_sentiment_score": "-0.089544", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMRSQ", "relevance_score": "0.044551", "ticker_sentiment_score": "0.305104", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ZYNE", "relevance_score": "0.044551", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.088964", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNXYF", "relevance_score": "0.044551", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Global Tissue Banking Market to Exhibit Growth at a Considerable CAGR of ~6% by 2030, Assesses DelveInsight", "url": "https://www.prnewswire.com/news-releases/global-tissue-banking-market-to-exhibit-growth-at-a-considerable-cagr-of-6-by-2030-assesses-delveinsight-302110459.html", "time_published": "20240409T214100", "authors": ["DelveInsight Business Research", "LLP"], "summary": "The tissue banking market is experiencing a surge in demand due to several factors: the growing prevalence and occurrence of chronic illnesses, the expanding elderly population susceptible to such ailments, and the potential breakthroughs in treating cancers, blood disorders, immune conditions, ...", "banner_image": "https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.222873, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PGEN", "relevance_score": "0.022991", "ticker_sentiment_score": "0.033133", "ticker_sentiment_label": "Neutral"}, {"ticker": "GBLX", "relevance_score": "0.022991", "ticker_sentiment_score": "0.033133", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.045962", "ticker_sentiment_score": "0.03774", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLFS", "relevance_score": "0.022991", "ticker_sentiment_score": "0.048471", "ticker_sentiment_label": "Neutral"}, {"ticker": "IONS", "relevance_score": "0.022991", "ticker_sentiment_score": "0.033133", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.022991", "ticker_sentiment_score": "0.033133", "ticker_sentiment_label": "Neutral"}, {"ticker": "MESO", "relevance_score": "0.022991", "ticker_sentiment_score": "0.033133", "ticker_sentiment_label": "Neutral"}, {"ticker": "SUVPF", "relevance_score": "0.022991", "ticker_sentiment_score": "0.048471", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATHXQ", "relevance_score": "0.022991", "ticker_sentiment_score": "0.033133", "ticker_sentiment_label": "Neutral"}, {"ticker": "EWTX", "relevance_score": "0.022991", "ticker_sentiment_score": "0.033133", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNY", "relevance_score": "0.022991", "ticker_sentiment_score": "0.037011", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCDA", "relevance_score": "0.022991", "ticker_sentiment_score": "0.033133", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNYA", "relevance_score": "0.022991", "ticker_sentiment_score": "0.033133", "ticker_sentiment_label": "Neutral"}, {"ticker": "PHCCF", "relevance_score": "0.022991", "ticker_sentiment_score": "0.048471", "ticker_sentiment_label": "Neutral"}, {"ticker": "SANA", "relevance_score": "0.022991", "ticker_sentiment_score": "0.033133", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDL", "relevance_score": "0.022991", "ticker_sentiment_score": "0.033133", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIO", "relevance_score": "0.022991", "ticker_sentiment_score": "0.048471", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVTR", "relevance_score": "0.022991", "ticker_sentiment_score": "0.048471", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCPH", "relevance_score": "0.022991", "ticker_sentiment_score": "0.033133", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.045962", "ticker_sentiment_score": "0.044896", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBIGF", "relevance_score": "0.022991", "ticker_sentiment_score": "0.033133", "ticker_sentiment_label": "Neutral"}, {"ticker": "WINT", "relevance_score": "0.045962", "ticker_sentiment_score": "0.044896", "ticker_sentiment_label": "Neutral"}, {"ticker": "LXRX", "relevance_score": "0.022991", "ticker_sentiment_score": "0.033133", "ticker_sentiment_label": "Neutral"}, {"ticker": "THMO", "relevance_score": "0.022991", "ticker_sentiment_score": "0.048471", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYTK", "relevance_score": "0.022991", "ticker_sentiment_score": "0.033133", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITCI", "relevance_score": "0.022991", "ticker_sentiment_score": "0.033133", "ticker_sentiment_label": "Neutral"}, {"ticker": "AZN", "relevance_score": "0.045962", "ticker_sentiment_score": "0.036735", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.022991", "ticker_sentiment_score": "0.048471", "ticker_sentiment_label": "Neutral"}, {"ticker": "AZTA", "relevance_score": "0.022991", "ticker_sentiment_score": "0.048471", "ticker_sentiment_label": "Neutral"}, {"ticker": "FUJIF", "relevance_score": "0.022991", "ticker_sentiment_score": "0.033133", "ticker_sentiment_label": "Neutral"}, {"ticker": "REGN", "relevance_score": "0.022991", "ticker_sentiment_score": "0.033133", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVO", "relevance_score": "0.022991", "ticker_sentiment_score": "0.033133", "ticker_sentiment_label": "Neutral"}]}, {"title": "Cardiol Therapeutics Announces Year-End 2023 Update on Operations", "url": "https://investingnews.com/cardiol-therapeutics-announces-year-end-2023-update-on-operations/", "time_published": "20240402T102035", "authors": ["Investing News Network"], "summary": "Completed patient enrollment in the Phase II MAvERIC-Pilot study evaluating CardiolRx\u2122 in patients with recurrent pericarditis, with topline results expected in Q2 2024 CardiolRx\u2122 granted U.S. FDA Orphan Drug Designation for the treatment of pericarditis, which includes recurrent pericarditis", "banner_image": "https://investingnews.com/media-library/image.png?id=50375659&width=1200&height=600&coordinates=0%2C75%2C0%2C75", "source": "Investing News Network", "category_within_source": "n/a", "source_domain": "investingnews.com", "topics": [{"topic": "Real Estate & Construction", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.169788, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "APG", "relevance_score": "0.109455", "ticker_sentiment_score": "0.035757", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDL", "relevance_score": "0.163539", "ticker_sentiment_score": "0.171719", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Cardiol Therapeutics Completes Patient Enrollment in its Phase II MAvERIC-Pilot Study Investigating CardiolRx for Recurrent Pericarditis", "url": "https://investingnews.com/cardiol-therapeutics-completes-patient-enrollment-in-its-phase-ii-maveric-pilot-study-investigating-cardiolrx-for-recurrent-pericarditis/", "time_published": "20240221T125223", "authors": ["Investing News Network"], "summary": "Cardiol Therapeutics Completes Patient Enrollment in its Phase II MAvERIC-Pilot Study Investigating CardiolRx for ... Investing News Network ...", "banner_image": "https://investingnews.com/media-library/image.png?id=50375659&width=1200&height=800", "source": "Investing News Network", "category_within_source": "n/a", "source_domain": "investingnews.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": 0.087583, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CRDL", "relevance_score": "0.244109", "ticker_sentiment_score": "0.226129", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Focus on Biotech Stocks:  ( NASDAQ: CRDL )   ( NASDAQ: KA )   ( TSXV: MDCX )   ( OTCQB: SKYE ) ", "url": "https://www.investorideas.com/news/2024/main/02161Stocks.asp", "time_published": "20240216T141652", "authors": [], "summary": "Focus on Biotech Stocks: ( NASDAQ: CRDL ) ( NASDAQ: KA ) ( TSXV: MDCX ) ( OTCQB: SKYE ...", "banner_image": null, "source": "Investor Ideas", "category_within_source": "n/a", "source_domain": "www.investorideas.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.938793"}], "overall_sentiment_score": 0.209291, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ONCY", "relevance_score": "0.061631", "ticker_sentiment_score": "-0.100506", "ticker_sentiment_label": "Neutral"}, {"ticker": "AIMD", "relevance_score": "0.061631", "ticker_sentiment_score": "0.14505", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRBO", "relevance_score": "0.061631", "ticker_sentiment_score": "0.078317", "ticker_sentiment_label": "Neutral"}, {"ticker": "KA", "relevance_score": "0.092331", "ticker_sentiment_score": "0.038554", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDL", "relevance_score": "0.092331", "ticker_sentiment_score": "0.149227", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTSG", "relevance_score": "0.030838", "ticker_sentiment_score": "0.27362", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ACHV", "relevance_score": "0.061631", "ticker_sentiment_score": "-0.004036", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDPLF", "relevance_score": "0.061631", "ticker_sentiment_score": "0.102546", "ticker_sentiment_label": "Neutral"}]}, {"title": "Cardiol Therapeutics Granted Orphan Drug Designation for its Lead Drug Candidate for the Treatment of Pericarditis", "url": "https://investingnews.com/cardiol-therapeutics-granted-orphan-drug-designation-for-its-lead-drug-candidate-for-the-treatment-of-pericarditis/", "time_published": "20240215T131003", "authors": ["Investing News Network"], "summary": "Designation Based on Pre-Clinical Data and Initial Clinical Data from the Company's MAvERIC-Pilot Phase II Study", "banner_image": "https://investingnews.com/media-library/image.png?id=50375659&width=1200&height=800", "source": "Investing News Network", "category_within_source": "n/a", "source_domain": "investingnews.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": 0.051569, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CRDL", "relevance_score": "0.251032", "ticker_sentiment_score": "0.159068", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Top 3 Canadian Biotech Stocks", "url": "https://investingnews.com/daily/life-science-investing/biotech-investing/top-canadian-biotech-stocks/", "time_published": "20240125T211500", "authors": ["Meagen Seatter"], "summary": "In this article, the Investing News Network takes a look at what the top three biotech companies trading on the Toronto Stock Exchange ( TSX ) and the Toronto Stock Exchange Venture ( TSXV ) have in store going into 2024.", "banner_image": "https://investingnews.com/media-library/laboratory-workers.jpg?id=30129521&width=1200&height=800&quality=85&coordinates=0%2C0%2C0%2C0", "source": "Investing News Network", "category_within_source": "n/a", "source_domain": "investingnews.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.967645"}], "overall_sentiment_score": 0.227136, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CRDL", "relevance_score": "0.071145", "ticker_sentiment_score": "0.085929", "ticker_sentiment_label": "Neutral"}, {"ticker": "KHTRF", "relevance_score": "0.071145", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SUPN", "relevance_score": "0.071145", "ticker_sentiment_score": "0.173193", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Drug-Eluting Balloons Global Market is Expected to Expand at a Healthy Growth Rate of ~8% by 2028, Predicts DelveInsight", "url": "https://www.prnewswire.com/news-releases/drug-eluting-balloons-global-market-is-expected-to-expand-at-a-healthy-growth-rate-of-8-by-2028-predicts-delveinsight-302042856.html", "time_published": "20240124T220100", "authors": ["LLP", "DelveInsight Business Research"], "summary": "Drug-Eluting Balloons Global Market is Expected to Expand at a Healthy Growth Rate of ~8% by 2028, Predicts ... PR ...", "banner_image": "https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.170441, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PGEN", "relevance_score": "0.025985", "ticker_sentiment_score": "0.033663", "ticker_sentiment_label": "Neutral"}, {"ticker": "GBLX", "relevance_score": "0.025985", "ticker_sentiment_score": "0.033663", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.025985", "ticker_sentiment_score": "0.033663", "ticker_sentiment_label": "Neutral"}, {"ticker": "IONS", "relevance_score": "0.025985", "ticker_sentiment_score": "0.033663", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.025985", "ticker_sentiment_score": "0.033663", "ticker_sentiment_label": "Neutral"}, {"ticker": "PHG", "relevance_score": "0.025985", "ticker_sentiment_score": "0.077292", "ticker_sentiment_label": "Neutral"}, {"ticker": "MESO", "relevance_score": "0.025985", "ticker_sentiment_score": "0.033663", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATHXQ", "relevance_score": "0.025985", "ticker_sentiment_score": "0.033663", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRDX", "relevance_score": "0.051943", "ticker_sentiment_score": "0.104731", "ticker_sentiment_label": "Neutral"}, {"ticker": "EWTX", "relevance_score": "0.025985", "ticker_sentiment_score": "0.033663", "ticker_sentiment_label": "Neutral"}, {"ticker": "LSTA", "relevance_score": "0.025985", "ticker_sentiment_score": "0.032293", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDT", "relevance_score": "0.025985", "ticker_sentiment_score": "0.077292", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCDA", "relevance_score": "0.025985", "ticker_sentiment_score": "0.033663", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNYA", "relevance_score": "0.025985", "ticker_sentiment_score": "0.033663", "ticker_sentiment_label": "Neutral"}, {"ticker": "BSX", "relevance_score": "0.051943", "ticker_sentiment_score": "0.048943", "ticker_sentiment_label": "Neutral"}, {"ticker": "SANA", "relevance_score": "0.025985", "ticker_sentiment_score": "0.033663", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDL", "relevance_score": "0.025985", "ticker_sentiment_score": "0.033663", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCPH", "relevance_score": "0.025985", "ticker_sentiment_score": "0.033663", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.025985", "ticker_sentiment_score": "0.033663", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBIGF", "relevance_score": "0.025985", "ticker_sentiment_score": "0.033663", "ticker_sentiment_label": "Neutral"}, {"ticker": "WINT", "relevance_score": "0.025985", "ticker_sentiment_score": "0.033663", "ticker_sentiment_label": "Neutral"}, {"ticker": "LXRX", "relevance_score": "0.025985", "ticker_sentiment_score": "0.033663", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYTK", "relevance_score": "0.025985", "ticker_sentiment_score": "0.033663", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITCI", "relevance_score": "0.025985", "ticker_sentiment_score": "0.033663", "ticker_sentiment_label": "Neutral"}, {"ticker": "AZN", "relevance_score": "0.025985", "ticker_sentiment_score": "0.033663", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRUMF", "relevance_score": "0.025985", "ticker_sentiment_score": "0.077292", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSBHF", "relevance_score": "0.025985", "ticker_sentiment_score": "-0.084826", "ticker_sentiment_label": "Neutral"}, {"ticker": "FUJIF", "relevance_score": "0.025985", "ticker_sentiment_score": "0.033663", "ticker_sentiment_label": "Neutral"}, {"ticker": "REGN", "relevance_score": "0.025985", "ticker_sentiment_score": "0.033663", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVO", "relevance_score": "0.025985", "ticker_sentiment_score": "0.033663", "ticker_sentiment_label": "Neutral"}]}, {"title": "Heart Failure Treatment Drug Market to Accelerate Immensely by 2032, Predicts DelveInsight", "url": "https://www.prnewswire.com/news-releases/heart-failure-treatment-drug-market-to-accelerate-immensely-by-2032-predicts-delveinsight-302034593.html", "time_published": "20240115T220500", "authors": ["DelveInsight Business Research", "LLP"], "summary": "The dynamics of the heart failure market are anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, raising awareness of the diseases, and incremental healthcare spending across the world.", "banner_image": "https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.165054, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BCDA", "relevance_score": "0.046861", "ticker_sentiment_score": "0.08891", "ticker_sentiment_label": "Neutral"}, {"ticker": "PGEN", "relevance_score": "0.023441", "ticker_sentiment_score": "0.03228", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNYA", "relevance_score": "0.023441", "ticker_sentiment_score": "0.03228", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.046861", "ticker_sentiment_score": "0.08891", "ticker_sentiment_label": "Neutral"}, {"ticker": "SANA", "relevance_score": "0.023441", "ticker_sentiment_score": "0.03228", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDL", "relevance_score": "0.023441", "ticker_sentiment_score": "0.03228", "ticker_sentiment_label": "Neutral"}, {"ticker": "IONS", "relevance_score": "0.023441", "ticker_sentiment_score": "0.03228", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.023441", "ticker_sentiment_score": "0.03228", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCPH", "relevance_score": "0.046861", "ticker_sentiment_score": "0.08891", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.093561", "ticker_sentiment_score": "0.092837", "ticker_sentiment_label": "Neutral"}, {"ticker": "MESO", "relevance_score": "0.046861", "ticker_sentiment_score": "0.08891", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBIGF", "relevance_score": "0.023441", "ticker_sentiment_score": "0.03228", "ticker_sentiment_label": "Neutral"}, {"ticker": "WINT", "relevance_score": "0.070242", "ticker_sentiment_score": "0.050911", "ticker_sentiment_label": "Neutral"}, {"ticker": "LXRX", "relevance_score": "0.046861", "ticker_sentiment_score": "0.08891", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYTK", "relevance_score": "0.046861", "ticker_sentiment_score": "0.08891", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITCI", "relevance_score": "0.046861", "ticker_sentiment_score": "0.08891", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATHXQ", "relevance_score": "0.023441", "ticker_sentiment_score": "0.03228", "ticker_sentiment_label": "Neutral"}, {"ticker": "AZN", "relevance_score": "0.046861", "ticker_sentiment_score": "0.08891", "ticker_sentiment_label": "Neutral"}, {"ticker": "EWTX", "relevance_score": "0.023441", "ticker_sentiment_score": "0.03228", "ticker_sentiment_label": "Neutral"}, {"ticker": "FUJIF", "relevance_score": "0.023441", "ticker_sentiment_score": "0.03228", "ticker_sentiment_label": "Neutral"}, {"ticker": "REGN", "relevance_score": "0.023441", "ticker_sentiment_score": "0.03228", "ticker_sentiment_label": "Neutral"}, {"ticker": "TENX", "relevance_score": "0.023441", "ticker_sentiment_score": "0.113992", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVO", "relevance_score": "0.023441", "ticker_sentiment_score": "0.03228", "ticker_sentiment_label": "Neutral"}]}, {"title": "Compass Pathways appoints Teri Loxam as Chief Financial Officer", "url": "https://investingnews.com/compass-pathways-appoints-teri-loxam-as-chief-financial-officer/", "time_published": "20231207T124337", "authors": ["Investing News Network"], "summary": "Compass Pathways plc ( Nasdaq: CMPS ) ( \"Compass\" ) , a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced that it has appointed Teri Loxam as Chief Financial Officer ( CFO ) , effective the beginning of March 2024.", "banner_image": "https://investingnews.com/media-library/eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJpbWFnZSI6Imh0dHBzOi8vYXNzZXRzLnJibC5tcy8yNTg1ODg1NS9vcmlnaW4ucG5nIiwiZXhwaXJlc19hdCI6MTcwODY4MTIxOX0.Phin9ClvosnPNpkGRdBWHz_VFepTco5fqEYZcXCsZIQ/image.png?width=210", "source": "Investing News Network", "category_within_source": "n/a", "source_domain": "investingnews.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.576289"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.187084, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CRDL", "relevance_score": "0.032513", "ticker_sentiment_score": "0.118414", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCVX", "relevance_score": "0.032513", "ticker_sentiment_score": "0.118414", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMAX", "relevance_score": "0.032513", "ticker_sentiment_score": "0.118414", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMPS", "relevance_score": "0.161494", "ticker_sentiment_score": "0.223503", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BMY", "relevance_score": "0.032513", "ticker_sentiment_score": "0.118414", "ticker_sentiment_label": "Neutral"}]}, {"title": "Compass Pathways appoints Teri Loxam as Chief Financial Officer - Compass Pathways  ( NASDAQ:CMPS ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36130382/compass-pathways-appoints-teri-loxam-as-chief-financial-officer", "time_published": "20231207T120000", "authors": ["Globe Newswire"], "summary": "LONDON, Dec. 07, 2023 ( GLOBE NEWSWIRE ) -- Compass Pathways plc CMPS ( \"Compass\" ) , a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced that it has appointed Teri Loxam as Chief Financial Officer ( CFO ) , effective ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.714479"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.168881, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CRDL", "relevance_score": "0.030759", "ticker_sentiment_score": "0.117589", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCVX", "relevance_score": "0.030759", "ticker_sentiment_score": "0.117589", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMAX", "relevance_score": "0.030759", "ticker_sentiment_score": "0.117589", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMPS", "relevance_score": "0.152886", "ticker_sentiment_score": "0.210529", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BMY", "relevance_score": "0.030759", "ticker_sentiment_score": "0.117589", "ticker_sentiment_label": "Neutral"}]}, {"title": "Cardiol Therapeutics Announces Massachusetts General Hospital, Largest Teaching Hospital of Harvard Medical School, as the 8th Major Medical Centre Participating in MAvERIC-Pilot", "url": "https://investingnews.com/cardiol-therapeutics-announces-massachusetts-general-hospital-largest-teaching-hospital-of-harvard-medical-school-as-the-8th-major-medical-centre-participating-in-maveric-pilot/", "time_published": "20231205T130339", "authors": ["Investing News Network"], "summary": "MAvERIC-Pilot is a Phase II Study in Recurrent Pericarditis and is Anticipated to Complete Patient Recruitment during Q1 2024", "banner_image": "https://investingnews.com/media-library/image.png?id=50375659&width=1200&height=800", "source": "Investing News Network", "category_within_source": "n/a", "source_domain": "investingnews.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": 0.104356, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CRDL", "relevance_score": "0.267193", "ticker_sentiment_score": "0.305725", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Cardiol Therapeutics Announces It Has Exceeded 50% Enrollment in Its Phase II MAvERIC-Pilot Study in Recurrent Pericarditis", "url": "https://investingnews.com/cardiol-therapeutics-announces-it-has-exceeded-50-enrollment-in-its-phase-ii-maveric-pilot-study-in-recurrent-pericarditis/", "time_published": "20231101T115108", "authors": ["Investing News Network"], "summary": "Cardiol Therapeutics Inc. ( NASDAQ: CRDL ) ( TSX: CRDL ) ( \"Cardiol\" or the \"Company\" ) , a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, is pleased to announce that it ...", "banner_image": "https://investingnews.com/media-library/image.png?id=33447706&width=1200&height=796", "source": "Investing News Network", "category_within_source": "n/a", "source_domain": "investingnews.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": 0.154215, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CRDL", "relevance_score": "0.274705", "ticker_sentiment_score": "0.289181", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Cardiol Therapeutics Fights Heart Inflammation With Novel Formulations - Cardiol Therapeutics  ( NASDAQ:CRDL ) ", "url": "https://www.benzinga.com/general/biotech/23/10/35220787/cardiol-therapeutics-fights-heart-inflammation-with-novel-formulations", "time_published": "20231012T135319", "authors": ["Beau Sharpe"], "summary": "697,000 people die from heart disease every year in the United States - that is one in every five deaths. In fact, cardiovascular disease is the number one killer for most Americans per the CDC. Everyday life choices play an essential role in heart health, and sometimes unfortunate accidents can ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/12/shutterstock_1381636952.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.096094, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CRDL", "relevance_score": "0.323927", "ticker_sentiment_score": "0.140733", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNA", "relevance_score": "0.066598", "ticker_sentiment_score": "-0.014349", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMGN", "relevance_score": "0.033328", "ticker_sentiment_score": "-0.01534", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.033328", "ticker_sentiment_score": "-0.056748", "ticker_sentiment_label": "Neutral"}]}, {"title": "CBD To Treat Heart Failure? New Study Shows Its Cardioprotective Effects - Cardiol Therapeutics  ( NASDAQ:CRDL ) ", "url": "https://www.benzinga.com/markets/cannabis/23/10/35165578/cbd-to-treat-heart-failure-new-study-shows-its-cardioprotective-effects", "time_published": "20231010T165703", "authors": ["Jelena Martinovic"], "summary": "On Tuesday, Cardiol Therapeutics Inc.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/10/untitled-1.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": 0.26576, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CRDL", "relevance_score": "0.319933", "ticker_sentiment_score": "0.341738", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Cardiol Therapeutics Announces Positive Study Results Demonstrating Cardioprotective Effects of Subcutaneously Administered Cannabidiol in a Model of Heart Failure with Preserved Ejection Fraction", "url": "https://investingnews.com/cardiol-therapeutics-announces-positive-study-results-demonstrating-cardioprotective-effects-of-subcutaneously-administered-cannabidiol-in-a-model-of-heart-failure-with-preserved-ejection-fraction/", "time_published": "20231010T102140", "authors": ["Investing News Network"], "summary": "Cardiol Therapeutics Announces Positive Study Results ... Investing News Network ...", "banner_image": "https://investingnews.com/media-library/image.png?id=33447706&width=1200&height=796", "source": "Investing News Network", "category_within_source": "n/a", "source_domain": "investingnews.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": 0.132438, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CRDL", "relevance_score": "0.212115", "ticker_sentiment_score": "0.185918", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Here's Why You May Invest in Cardiol Therapeutics  ( CRDL )  Stock", "url": "https://www.zacks.com/stock/news/2156104/heres-why-you-may-invest-in-cardiol-therapeutics-crdl-stock", "time_published": "20230927T133400", "authors": ["Zacks Equity Research"], "summary": "Here we discuss some reasons why investing in Cardiol Therapeutics (CRDL) stock now may turn out to be a prudent move.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/67/1932.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.890401"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.262465, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CRDL", "relevance_score": "0.361802", "ticker_sentiment_score": "0.240175", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CORT", "relevance_score": "0.149192", "ticker_sentiment_score": "0.069376", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUPH", "relevance_score": "0.361802", "ticker_sentiment_score": "0.2687", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ALPN", "relevance_score": "0.149192", "ticker_sentiment_score": "0.069376", "ticker_sentiment_label": "Neutral"}]}, {"title": "Is it a Good Time to Invest in Aurinia Pharmaceuticals  ( AUPH ) ?", "url": "https://www.zacks.com/stock/news/2156111/is-it-a-good-time-to-invest-in-aurinia-pharmaceuticals-auph", "time_published": "20230927T133400", "authors": ["Zacks Equity Research"], "summary": "Here we discuss why investing in Aurinia Pharmaceuticals (AUPH) stock now may be a prudent move.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/07/905.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Earnings", "relevance_score": "0.838487"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.235487, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CRDL", "relevance_score": "0.31482", "ticker_sentiment_score": "0.085809", "ticker_sentiment_label": "Neutral"}, {"ticker": "CORT", "relevance_score": "0.160633", "ticker_sentiment_score": "0.072641", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUPH", "relevance_score": "0.456884", "ticker_sentiment_score": "0.361809", "ticker_sentiment_label": "Bullish"}, {"ticker": "ALPN", "relevance_score": "0.160633", "ticker_sentiment_score": "0.072641", "ticker_sentiment_label": "Neutral"}]}, {"title": "Cardiol Therapeutics to Present at Cantor Fitzgerald 2023 Global Healthcare Conference", "url": "https://investingnews.com/cardiol-therapeutics-to-present-at-cantor-fitzgerald-2023-global-healthcare-conference/", "time_published": "20230926T115140", "authors": ["Investing News Network"], "summary": "Cardiol Therapeutics Inc. ( NASDAQ: CRDL ) ( TSX: CRDL ) ( \"Cardiol\" or the \"Company\" ) , a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, is pleased to announce that ...", "banner_image": "https://mma.prnewswire.com/media/152881/amgen_logo.jpg", "source": "Investing News Network", "category_within_source": "n/a", "source_domain": "investingnews.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": 0.08498, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CRDL", "relevance_score": "0.358521", "ticker_sentiment_score": "0.324014", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Why Murphy Canyon Acquisition Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket - Alliance Entertainment  ( NASDAQ:AENT ) , Antelope Ent Hldgs  ( NASDAQ:AEHL ) ", "url": "https://www.benzinga.com/news/23/09/34789115/why-murphy-canyon-acquisition-shares-are-trading-higher-by-around-32-here-are-20-stocks-moving-prema", "time_published": "20230921T115135", "authors": ["Lisa Levin"], "summary": "Near Intelligence, Inc. NIR shares rose 34.1% to $0.2801 in pre-market trading after falling 42% on Wednesday. Near Intelligence recently named its General Counsel, Jay Angelo, to also serve as the company's Chief Privacy Officer. Neptune Wellness Solutions Inc.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/09/21/image19_0.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "IPO", "relevance_score": "0.310843"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Real Estate & Construction", "relevance_score": "0.2"}], "overall_sentiment_score": 0.046355, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "KZR", "relevance_score": "0.229872", "ticker_sentiment_score": "0.260316", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MS", "relevance_score": "0.077593", "ticker_sentiment_score": "0.165194", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CRDL", "relevance_score": "0.154455", "ticker_sentiment_score": "0.253528", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "UPTD", "relevance_score": "0.154455", "ticker_sentiment_score": "0.184991", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "KRKR", "relevance_score": "0.154455", "ticker_sentiment_score": "-0.017147", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIFW", "relevance_score": "0.154455", "ticker_sentiment_score": "0.175911", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ARBB", "relevance_score": "0.154455", "ticker_sentiment_score": "-0.483249", "ticker_sentiment_label": "Bearish"}, {"ticker": "RNAZ", "relevance_score": "0.154455", "ticker_sentiment_score": "-0.216083", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AENT", "relevance_score": "0.154455", "ticker_sentiment_score": "0.23826", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "KERN", "relevance_score": "0.154455", "ticker_sentiment_score": "-0.08665", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEHL", "relevance_score": "0.229872", "ticker_sentiment_score": "-0.34911", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NIR", "relevance_score": "0.229872", "ticker_sentiment_score": "0.031977", "ticker_sentiment_label": "Neutral"}, {"ticker": "MURF", "relevance_score": "0.229872", "ticker_sentiment_score": "0.368333", "ticker_sentiment_label": "Bullish"}, {"ticker": "HSCS", "relevance_score": "0.154455", "ticker_sentiment_score": "-0.234681", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "VINO", "relevance_score": "0.154455", "ticker_sentiment_score": "-0.351758", "ticker_sentiment_label": "Bearish"}, {"ticker": "AVGR", "relevance_score": "0.229872", "ticker_sentiment_score": "0.056487", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEPT", "relevance_score": "0.154455", "ticker_sentiment_score": "0.214645", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SEEL", "relevance_score": "0.229872", "ticker_sentiment_score": "-0.365143", "ticker_sentiment_label": "Bearish"}]}, {"title": "Is Cardiol Therapeutics  ( CRDL )  Stock Outpacing Its Medical Peers This Year?", "url": "https://www.zacks.com/stock/news/2152478/is-cardiol-therapeutics-crdl-stock-outpacing-its-medical-peers-this-year", "time_published": "20230919T134009", "authors": ["Zacks Equity Research"], "summary": "Here is how Cardiol Therapeutics Inc. (CRDL) and DiaMedica Therapeutics, Inc. (DMAC) have performed compared to their sector so far this year.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default306.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}, {"topic": "Earnings", "relevance_score": "0.614606"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.230153, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CRDL", "relevance_score": "0.717937", "ticker_sentiment_score": "0.337697", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DMAC", "relevance_score": "0.4499", "ticker_sentiment_score": "0.280267", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Zacks Industry Outlook Highlights Corcept Therapeutics, Aurinia Pharmaceuticals, Alpine Immune Sciences, KalVista Pharmaceuticals and Cardiol Therapeutics", "url": "https://www.zacks.com/stock/news/2152417/zacks-industry-outlook-highlights-corcept-therapeutics-aurinia-pharmaceuticals-alpine-immune-sciences-kalvista-pharmaceuticals-and-cardiol-therapeutics", "time_published": "20230919T121600", "authors": ["Zacks Equity Research"], "summary": "Corcept Therapeutics, Aurinia Pharmaceuticals, Alpine Immune Sciences, KalVista Pharmaceuticals and Cardiol Therapeutics are part of the Zacks Industry Outlook article.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/f2/4113.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.310843"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.209213, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CRDL", "relevance_score": "0.110209", "ticker_sentiment_score": "-0.007934", "ticker_sentiment_label": "Neutral"}, {"ticker": "CORT", "relevance_score": "0.110209", "ticker_sentiment_score": "0.14557", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUPH", "relevance_score": "0.164656", "ticker_sentiment_score": "0.111093", "ticker_sentiment_label": "Neutral"}, {"ticker": "KALV", "relevance_score": "0.191603", "ticker_sentiment_score": "0.014052", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALPN", "relevance_score": "0.164656", "ticker_sentiment_score": "0.048372", "ticker_sentiment_label": "Neutral"}]}, {"title": "Cardiol Therapeutics Announces All Collaborating Clinical Research Centers Now Initiated and Eligible to Enroll Patients in ARCHER, a Phase II Trial of CardiolRx for the Treatment of Acute Myocarditis", "url": "https://investingnews.com/cardiol-therapeutics-announces-all-collaborating-clinical-research-centers-now-initiated-and-eligible-to-enroll-patients-in-archer-a-phase-ii-trial-of-cardiolrx-for-the-treatment-of-acute-myocarditis/", "time_published": "20230919T115046", "authors": ["Investing News Network"], "summary": "Cardiol Therapeutics Inc. ( NASDAQ: CRDL ) ( TSX: CRDL ) ( \"Cardiol\" or the \"Company\" ) , a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, today announces that all ...", "banner_image": "https://investingnews.com/media-library/image.png?id=33447706&width=1200&height=796", "source": "Investing News Network", "category_within_source": "n/a", "source_domain": "investingnews.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": 0.116335, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CRDL", "relevance_score": "0.261818", "ticker_sentiment_score": "0.176868", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "5 Stocks to Buy as Drug Industry Displays Strong Fundamentals", "url": "https://www.zacks.com/commentary/2151195/5-stocks-to-buy-as-drug-industry-displays-strong-fundamentals", "time_published": "20230918T125200", "authors": ["Kinjel Shah"], "summary": "Innovation is expected to continue driving growth in the Medical-Drugs industry. CORT, AUPH, ALPN, KALV and CRDL may prove to be good additions to one's portfolio.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/f5/952.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.999996"}, {"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.310843"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.197839, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CRDL", "relevance_score": "0.114001", "ticker_sentiment_score": "0.092889", "ticker_sentiment_label": "Neutral"}, {"ticker": "CORT", "relevance_score": "0.114001", "ticker_sentiment_score": "0.092889", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUPH", "relevance_score": "0.142228", "ticker_sentiment_score": "0.103587", "ticker_sentiment_label": "Neutral"}, {"ticker": "KALV", "relevance_score": "0.198106", "ticker_sentiment_score": "0.129609", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALPN", "relevance_score": "0.170275", "ticker_sentiment_score": "0.116136", "ticker_sentiment_label": "Neutral"}]}, {"title": "Cardiol Therapeutics Inc.  ( CRDL )  Forms 'Hammer Chart Pattern': Time for Bottom Fishing?", "url": "https://www.zacks.com/stock/news/2148357/cardiol-therapeutics-inc-crdl-forms-hammer-chart-pattern-time-for-bottom-fishing", "time_published": "20230913T135503", "authors": ["Zacks Equity Research"], "summary": "After losing some value lately, a hammer chart pattern has been formed for Cardiol Therapeutics Inc. (CRDL), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default94.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.875462"}, {"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.413559"}], "overall_sentiment_score": 0.18729, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CRDL", "relevance_score": "0.415699", "ticker_sentiment_score": "0.401043", "ticker_sentiment_label": "Bullish"}]}, {"title": "Cardiol Therapeutics Inc.  ( CRDL )  Upgraded to Buy: Here's What You Should Know", "url": "https://www.zacks.com/stock/news/2137141/cardiol-therapeutics-inc-crdl-upgraded-to-buy-heres-what-you-should-know", "time_published": "20230816T160006", "authors": ["Zacks Equity Research"], "summary": "Cardiol Therapeutics Inc. (CRDL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default319.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.997845"}, {"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.692272"}], "overall_sentiment_score": 0.303655, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CRDL", "relevance_score": "0.359881", "ticker_sentiment_score": "0.338524", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Cardiol Therapeutics to Present at Canaccord Genuity 43rd Annual Growth Conference", "url": "https://investingnews.com/cardiol-therapeutics-to-present-at-canaccord-genuity-43rd-annual-growth-conference-2663077837/", "time_published": "20230809T122246", "authors": ["Investing News Network"], "summary": "Cardiol Therapeutics Inc. ( NASDAQ: CRDL ) ( TSX: CRDL ) ( \"Cardiol\" or the \"Company\" ) , a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, is pleased to announce that ...", "banner_image": "https://mma.prnewswire.com/media/152881/amgen_logo.jpg", "source": "Investing News Network", "category_within_source": "n/a", "source_domain": "investingnews.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": 0.094741, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CCORF", "relevance_score": "0.054236", "ticker_sentiment_score": "0.150794", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CRDL", "relevance_score": "0.366061", "ticker_sentiment_score": "0.363517", "ticker_sentiment_label": "Bullish"}]}, {"title": "Cardiol Therapeutics to Present at Canaccord Genuity 43rd Annual Growth Conference", "url": "https://investingnews.com/cardiol-therapeutics-to-present-at-canaccord-genuity-43rd-annual-growth-conference/", "time_published": "20230809T115253", "authors": ["Investing News Network"], "summary": "Cardiol Therapeutics Inc. ( NASDAQ: CRDL ) ( TSX: CRDL ) ( \"Cardiol\" or the \"Company\" ) , a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, is pleased to announce that ...", "banner_image": "https://mma.prnewswire.com/media/152881/amgen_logo.jpg", "source": "Investing News Network", "category_within_source": "n/a", "source_domain": "investingnews.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": 0.094741, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CCORF", "relevance_score": "0.054236", "ticker_sentiment_score": "0.150794", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CRDL", "relevance_score": "0.366061", "ticker_sentiment_score": "0.363517", "ticker_sentiment_label": "Bullish"}]}, {"title": "Cardiol Therapeutics to Webcast Virtual Annual General Meeting on June 28th at 4:30 p.m. EDT", "url": "https://investingnews.com/cardiol-therapeutics-to-webcast-virtual-annual-general-meeting-on-june-28th-at-4-30-p-m-edt-2661984711/", "time_published": "20230628T142428", "authors": [], "summary": "Cardiol Therapeutics Inc. ( NASDAQ: CRDL ) ( TSX: CRDL ) ( \"Cardiol\" or the \"Company\" ) , a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, today announces its year-end 2022 ...", "banner_image": "https://investingnews.com/media-library/cardiol-therapeutics-tsx-crdl.png?id=33447706&width=1200&height=796", "source": "Investing News Network", "category_within_source": "n/a", "source_domain": "investingnews.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": 0.316539, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CRDL", "relevance_score": "0.532941", "ticker_sentiment_score": "0.426769", "ticker_sentiment_label": "Bullish"}]}, {"title": "Are Medical Stocks Lagging ANI Pharmaceuticals  ( ANIP )  This Year?", "url": "https://www.zacks.com/stock/news/2111762/are-medical-stocks-lagging-ani-pharmaceuticals-anip-this-year", "time_published": "20230622T134010", "authors": ["Zacks Investment Research"], "summary": "Here is how ANI Pharmaceuticals (ANIP) and Cardiol Therapeutics Inc. (CRDL) have performed compared to their sector so far this year.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default7.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}, {"topic": "Earnings", "relevance_score": "0.714479"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.305241, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CRDL", "relevance_score": "0.45634", "ticker_sentiment_score": "0.291053", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ANIP", "relevance_score": "0.725658", "ticker_sentiment_score": "0.495217", "ticker_sentiment_label": "Bullish"}]}, {"title": "Cardiol Therapeutics Announces Year-End 2022 Update on Operations - Investing News Network", "url": "https://investingnews.com/cardiol-therapeutics-announces-year-end-2022-update-on-operations/", "time_published": "20230329T113406", "authors": [], "summary": "Cardiol Therapeutics Announces Year-End 2022 Update on Operations Investing News Network ...", "banner_image": null, "source": "Investing News Network", "category_within_source": "n/a", "source_domain": "investingnews.com", "topics": [{"topic": "Real Estate & Construction", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.180987, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "APG", "relevance_score": "0.047216", "ticker_sentiment_score": "0.064791", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDL", "relevance_score": "0.12546", "ticker_sentiment_score": "0.165683", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Cardiol Therapeutics Announces Study Results from Collaborating Research Center Demonstrating Cardioprotective Effects of Cannabidiol in a Model of Heart Failure", "url": "https://investingnews.com/cardiol-therapeutics-announces-study-results-from-collaborating-research-center-demonstrating-cardioprotective-effects-of-cannabidiol-in-a-model-of-heart-failure/", "time_published": "20230307T123400", "authors": [], "summary": "Data Presented at The American College of Cardiology's 72nd Annual Scientific Session Together with the World Congress of Cardiology", "banner_image": "https://investingnews.com/media-library/image.jpg?id=27866453&width=1200&height=801", "source": "Investing News Network", "category_within_source": "n/a", "source_domain": "investingnews.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": 0.173847, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CRDL", "relevance_score": "0.234119", "ticker_sentiment_score": "0.242098", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Cardiol Therapeutics Announces First Patient Enrolled in Phase II Study Evaluating CardiolRx for the Treatment of Recurrent Pericarditis", "url": "https://investingnews.com/cardiol-therapeutics-announces-first-patient-enrolled-in-phase-ii-study-evaluating-cardiolrx-for-the-treatment-of-recurrent-pericarditis/", "time_published": "20230117T123700", "authors": [], "summary": "The Cleveland Clinic Recruits First Participant in the Multi-center U.S. Study", "banner_image": "https://investingnews.com/media-library/image.jpg?id=27866453&width=1200&height=801", "source": "Investing News Network", "category_within_source": "n/a", "source_domain": "investingnews.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": 0.087658, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CRDL", "relevance_score": "0.210144", "ticker_sentiment_score": "0.261671", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Cardiol Therapeutics Commences Multi-Center Phase II Pilot Study of CardiolRx for the Treatment of Recurrent Pericarditis", "url": "https://investingnews.com/cardiol-therapeutics-commences-multi-center-phase-ii-pilot-study-of-cardiolrx-for-the-treatment-of-recurrent-pericarditis/", "time_published": "20221212T154807", "authors": [], "summary": "Cardiol Therapeutics Inc. ( NASDAQ: CRDL ) ( TSX: CRDL ) ( \"Cardiol\" or the \"Company\" ) , a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases, announced today the initiation ...", "banner_image": "https://mma.prnewswire.com/media/152881/amgen_logo.jpg", "source": "Investing News Network", "category_within_source": "n/a", "source_domain": "investingnews.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": 0.087891, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CRDL", "relevance_score": "0.245649", "ticker_sentiment_score": "0.208315", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Here's Why Cardiol Therapeutics Inc.  ( CRDL )  Could be Great Choice for a Bottom Fisher", "url": "https://www.zacks.com/stock/news/2017386/heres-why-cardiol-therapeutics-inc-crdl-could-be-great-choice-for-a-bottom-fisher", "time_published": "20221111T145504", "authors": ["Zacks Investment Research"], "summary": "Cardiol Therapeutics Inc. (CRDL) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default335.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.875462"}, {"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.230094, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CRDL", "relevance_score": "0.414559", "ticker_sentiment_score": "0.438377", "ticker_sentiment_label": "Bullish"}]}, {"title": "Cardiol Therapeutics Announces Study Results Demonstrating Protective Effects of CardiolRx in a Model of Acute Pericarditis", "url": "https://investingnews.com/cardiol-therapeutics-announces-study-results-demonstrating-protective-effects-of-cardiolrx-in-a-model-of-acute-pericarditis/", "time_published": "20221107T123806", "authors": [], "summary": "Cardiol Therapeutics Inc. ( NASDAQ: CRDL ) ( TSX: CRDL ) ( \"Cardiol\" or the \"Company\" ) , a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases, announced today study results ...", "banner_image": "https://mma.prnewswire.com/media/152881/amgen_logo.jpg", "source": "Investing News Network", "category_within_source": "n/a", "source_domain": "investingnews.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": 0.079737, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CRDL", "relevance_score": "0.170878", "ticker_sentiment_score": "0.119169", "ticker_sentiment_label": "Neutral"}]}, {"title": "Cardiol Therapeutics Prioritizes Phase II Clinical Programs in Underserved Heart Diseases - Investing News Network", "url": "https://investingnews.com/cardiol-therapeutics-prioritizes-phase-ii-clinical-programs-in-underserved-heart-diseases/", "time_published": "20221025T104838", "authors": [], "summary": "Cardiol Therapeutics Prioritizes Phase II Clinical Programs in Underserved Heart Diseases Investing News Network ...", "banner_image": null, "source": "Investing News Network", "category_within_source": "n/a", "source_domain": "investingnews.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": 0.058562, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CRDL", "relevance_score": "0.189298", "ticker_sentiment_score": "0.248845", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Cardiol Therapeutics Announces Pre-Clinical Study Results Demonstrating CardiolRx Inhibits and also Promotes Reversal of Mechanisms Leading to Cardiac Fibrosis", "url": "https://investingnews.com/cardiol-therapeutics-announces-pre-clinical-study-results-demonstrating-cardiolrx-inhibits-and-also-promotes-reversal-of-mechanisms-leading-to-cardiac-fibrosis/", "time_published": "20221003T113424", "authors": [], "summary": "Data Presented at The Annual Scientific Meeting of the Heart Failure Society of America September 30th, 2022", "banner_image": null, "source": "Investing News Network", "category_within_source": "n/a", "source_domain": "investingnews.com", "topics": [{"topic": "Real Estate & Construction", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.0821, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "APG", "relevance_score": "0.066784", "ticker_sentiment_score": "0.101643", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDL", "relevance_score": "0.262522", "ticker_sentiment_score": "0.209623", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Cardiol Therapeutics Announces Poster Presentation at The Annual Scientific Meeting of the Heart Failure Society of America", "url": "https://investingnews.com/cardiol-therapeutics-announces-poster-presentation-at-the-annual-scientific-meeting-of-the-heart-failure-society-of-america/", "time_published": "20220928T124125", "authors": [], "summary": "Cardiol Therapeutics Inc. ( NASDAQ: CRDL ) ( TSX: CRDL ) ( \"Cardiol\" or the \"Company\" ) , a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of cardiovascular diseases ( \"CVD\" ) , announced ...", "banner_image": null, "source": "Investing News Network", "category_within_source": "n/a", "source_domain": "investingnews.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": 0.034055, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CRDL", "relevance_score": "0.357783", "ticker_sentiment_score": "0.245539", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Proactive news headlines including Robinhood, Progressive Planet, BioLargo, Metal Tiger, New Age Metals, ImagineAR, American Manganese and Marble Financial", "url": "https://www.benzinga.com/pressreleases/22/08/g28338520/proactive-news-headlines-including-robinhood-progressive-planet-biolargo-metal-tiger-new-age-metal", "time_published": "20220803T181853", "authors": ["Globe Newswire"], "summary": "New York , Aug. 03, 2022 ( GLOBE NEWSWIRE ) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies: Trading slump hits Robinhood's revenues as retail investors tap out click here", "banner_image": "", "source": "Benzinga", "category_within_source": "Mergers", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}, {"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.27297, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.037741", "ticker_sentiment_score": "0.121706", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDXHF", "relevance_score": "0.037741", "ticker_sentiment_score": "-0.145313", "ticker_sentiment_label": "Neutral"}, {"ticker": "FBCPF", "relevance_score": "0.037741", "ticker_sentiment_score": "0.132512", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRBLF", "relevance_score": "0.037741", "ticker_sentiment_score": "0.155181", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GEVO", "relevance_score": "0.037741", "ticker_sentiment_score": "0.336123", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BRAXF", "relevance_score": "0.037741", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDL", "relevance_score": "0.037741", "ticker_sentiment_score": "0.153206", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MEDH", "relevance_score": "0.037741", "ticker_sentiment_score": "-0.145313", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRNBF", "relevance_score": "0.037741", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "IZCFF", "relevance_score": "0.037741", "ticker_sentiment_score": "0.138416", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRC", "relevance_score": "0.037741", "ticker_sentiment_score": "-0.130545", "ticker_sentiment_label": "Neutral"}]}, {"title": "Cardiol Therapeutics Announces First Patient Enrolled in ARCHER, a Phase II Clinical Trial of CardiolRx for Treatment of Acute Myocarditis", "url": "https://investingnews.com/cardiol-therapeutics-announces-first-patient-enrolled-in-archer-a-phase-ii-clinical-trial-of-cardiolrx-for-treatment-of-acute-myocarditis/", "time_published": "20220803T120623", "authors": [], "summary": "Multi-center, international, double-blind, randomized, placebo-controlled trial to enroll 100 patients", "banner_image": null, "source": "Investing News Network", "category_within_source": "n/a", "source_domain": "investingnews.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": 0.036542, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CRDL", "relevance_score": "0.208336", "ticker_sentiment_score": "0.142935", "ticker_sentiment_label": "Neutral"}]}, {"title": "Cardiol Therapeutics Reports Results of 2022 Annual General Meeting", "url": "https://investingnews.com/cardiol-therapeutics-reports-results-of-2022-annual-general-meeting/", "time_published": "20220629T143659", "authors": [], "summary": "Cardiol Therapeutics Inc. ( NASDAQ: CRDL ) ( TSX: CRDL ) ( \"Cardiol\" or the \"Company\" ) , a clinical-stage life sciences company focused on the research and clinical development of cannabidiol as an anti-inflammatory and anti-fibrotic therapy for the treatment of cardiovascular diseases ( \"CVD\" ...", "banner_image": "https://investingnews.com/media-library/image.jpg?id=27866453&width=1200&coordinates=0%2C42%2C0%2C42&height=600", "source": "Investing News Network", "category_within_source": "n/a", "source_domain": "investingnews.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": 0.004444, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CRDL", "relevance_score": "0.244256", "ticker_sentiment_score": "0.004444", "ticker_sentiment_label": "Neutral"}]}, {"title": "Cardiol Therapeutics to Webcast Virtual Annual General Meeting on June 28th at 4:30 P.M. EDT", "url": "https://investingnews.com/cardiol-therapeutics-to-webcast-virtual-annual-general-meeting-on-june-28th-at-4-30-p-m-edt/", "time_published": "20220627T143202", "authors": [], "summary": "Cardiol Therapeutics Inc. ( NASDAQ: CRDL ) ( TSX: CRDL ) ( \"Cardiol\" or the \"Company\" ) , a clinical-stage life sciences company focused on the research and clinical development of cannabidiol as an anti-inflammatory and anti-fibrotic therapy for the treatment of cardiovascular diseases ( \"CVD\" ...", "banner_image": "https://mms.businesswire.com/media/20220427005982/en/1436129/4/Product_Image.jpg", "source": "Investing News Network", "category_within_source": "n/a", "source_domain": "investingnews.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": 0.00896, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CRDL", "relevance_score": "0.241972", "ticker_sentiment_score": "0.00896", "ticker_sentiment_label": "Neutral"}]}, {"title": "Cardiol Therapeutics Announces At-The-Market Equity Offering Program", "url": "https://investingnews.com/cardiol-therapeutics-announces-at-the-market-equity-offering-program/", "time_published": "20220609T203825", "authors": [], "summary": "Cardiol Therapeutics Inc. ( NASDAQ: CRDL ) ( TSX: CRDL ) ( \"Cardiol\" or the \"Company\" ) , a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of cardiovascular disease, is pleased to announce ...", "banner_image": null, "source": "Investing News Network", "category_within_source": "n/a", "source_domain": "investingnews.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.839681"}], "overall_sentiment_score": 0.010702, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CCORF", "relevance_score": "0.07597", "ticker_sentiment_score": "0.023207", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDL", "relevance_score": "0.151254", "ticker_sentiment_score": "0.034865", "ticker_sentiment_label": "Neutral"}]}, {"title": "CEO Presenting on the Emerging Growth Conference on May 25 Register Now", "url": "https://investingnews.com/ceo-presenting-on-the-emerging-growth-conference-on-may-25-register-now/", "time_published": "20220525T174919", "authors": [], "summary": "EmergingGrowth.com a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth Companies and Markets announces the Schedule of the 31 st Emerging Growth Conference.", "banner_image": "https://www.accesswire.com/users/newswire/images/694441/pn1.jpeg", "source": "Investing News Network", "category_within_source": "n/a", "source_domain": "investingnews.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.967645"}, {"topic": "Real Estate & Construction", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.104404, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SIDU", "relevance_score": "0.112638", "ticker_sentiment_score": "0.000631", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTRB", "relevance_score": "0.112638", "ticker_sentiment_score": "0.000528", "ticker_sentiment_label": "Neutral"}, {"ticker": "FMNJ", "relevance_score": "0.112638", "ticker_sentiment_score": "0.000738", "ticker_sentiment_label": "Neutral"}, {"ticker": "CAVR", "relevance_score": "0.112638", "ticker_sentiment_score": "0.002708", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDL", "relevance_score": "0.112638", "ticker_sentiment_score": "0.000675", "ticker_sentiment_label": "Neutral"}, {"ticker": "COSM", "relevance_score": "0.05646", "ticker_sentiment_score": "0.000765", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNVCF", "relevance_score": "0.112638", "ticker_sentiment_score": "0.000538", "ticker_sentiment_label": "Neutral"}]}, {"title": "CEO Presenting on the Emerging Growth Conference on May 25 Register Now", "url": "https://www.benzinga.com/pressreleases/22/05/g27364769/ceo-presenting-on-the-emerging-growth-conference-on-may-25-register-now", "time_published": "20220524T110000", "authors": ["Globe Newswire"], "summary": "MIAMI, May 24, 2022 ( GLOBE NEWSWIRE ) -- EmergingGrowth.com a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth Companies and Markets announces the Schedule of the 31st Emerging Growth Conference. The Emerging Growth C", "banner_image": "https://ml.globenewswire.com/media/94024ad3-4875-44da-ae94-00a1c306b67e/small/logo-egc-pr-image-globe-yahoo-png.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.929393"}, {"topic": "Real Estate & Construction", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.094196, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SIDU", "relevance_score": "0.11349", "ticker_sentiment_score": "0.000355", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTRB", "relevance_score": "0.11349", "ticker_sentiment_score": "0.000398", "ticker_sentiment_label": "Neutral"}, {"ticker": "FMNJ", "relevance_score": "0.11349", "ticker_sentiment_score": "0.000676", "ticker_sentiment_label": "Neutral"}, {"ticker": "CAVR", "relevance_score": "0.11349", "ticker_sentiment_score": "0.003591", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDL", "relevance_score": "0.169517", "ticker_sentiment_score": "0.000649", "ticker_sentiment_label": "Neutral"}, {"ticker": "COSM", "relevance_score": "0.11349", "ticker_sentiment_score": "0.000519", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNVCF", "relevance_score": "0.11349", "ticker_sentiment_score": "0.000827", "ticker_sentiment_label": "Neutral"}]}, {"title": "Proactive news headlines including EverGen Infrastructure, ACME Lithium, Cardiol Therapeutics, Tocvan Ventures, South Star Battery Metals, Alkaline Fuel Cell Power", "url": "https://www.benzinga.com/pressreleases/22/05/g27309649/proactive-news-headlines-including-evergen-infrastructure-acme-lithium-cardiol-therapeutics-tocvan", "time_published": "20220519T175234", "authors": ["Globe Newswire"], "summary": "New York , May 19, 2022 ( GLOBE NEWSWIRE ) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies: CO2 GRO announces the start of a technology trial with a Canada-based cucumber greenhouse click here Auri", "banner_image": "", "source": "Benzinga", "category_within_source": "Mergers", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}, {"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.003052, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BELMF", "relevance_score": "0.083483", "ticker_sentiment_score": "0.010942", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDL", "relevance_score": "0.083483", "ticker_sentiment_score": "0.003807", "ticker_sentiment_label": "Neutral"}, {"ticker": "POAI", "relevance_score": "0.083483", "ticker_sentiment_score": "0.001959", "ticker_sentiment_label": "Neutral"}]}, {"title": "Cardiol Therapeutics Appoints Teri Loxam and Chris Waddick to its Board of Directors", "url": "https://investingnews.com/cardiol-therapeutics-appoints-teri-loxam-and-chris-waddick-to-its-board-of-directors/", "time_published": "20220519T114357", "authors": [], "summary": "", "banner_image": null, "source": "Investing News Network", "category_within_source": "n/a", "source_domain": "investingnews.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "IPO", "relevance_score": "0.576289"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.076646, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CRDL", "relevance_score": "0.170958", "ticker_sentiment_score": "0.150821", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PCVX", "relevance_score": "0.028708", "ticker_sentiment_score": "0.024397", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMAX", "relevance_score": "0.028708", "ticker_sentiment_score": "0.024397", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGA", "relevance_score": "0.028708", "ticker_sentiment_score": "0.026424", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.028708", "ticker_sentiment_score": "0.024397", "ticker_sentiment_label": "Neutral"}]}, {"title": "76 Biggest Movers From Yesterday", "url": "https://www.benzinga.com/news/22/05/27294922/76-biggest-movers-from-yesterday", "time_published": "20220519T084523", "authors": ["Lisa Levin"], "summary": "Gainers Bright Green Corp. ( NASDAQ: BGXX ) jumped 90.5% to close at $48.08 on Wednesday. Bright Green Corporation, went public on the NASDAQ Tuesday, becoming the first U.S. plant-touching company to list on a major U.S. stock exchange. Decisionpoint Systems, Inc. ( NYSE: DPSI ) shares climbed", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/05/19/yesterdays_movers.png?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "IPO", "relevance_score": "0.576289"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.918141"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "0.999992"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.052085, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PEGY", "relevance_score": "0.050238", "ticker_sentiment_score": "-0.088588", "ticker_sentiment_label": "Neutral"}, {"ticker": "BXRX", "relevance_score": "0.050238", "ticker_sentiment_score": "-0.000308", "ticker_sentiment_label": "Neutral"}, {"ticker": "DG", "relevance_score": "0.050238", "ticker_sentiment_score": "-0.5945", "ticker_sentiment_label": "Bearish"}, {"ticker": "EVEX", "relevance_score": "0.050238", "ticker_sentiment_score": "0.001539", "ticker_sentiment_label": "Neutral"}, {"ticker": "STG", "relevance_score": "0.050238", "ticker_sentiment_score": "-0.000472", "ticker_sentiment_label": "Neutral"}, {"ticker": "WOOF", "relevance_score": "0.075294", "ticker_sentiment_score": "0.015502", "ticker_sentiment_label": "Neutral"}, {"ticker": "EWCZ", "relevance_score": "0.075294", "ticker_sentiment_score": "-0.023532", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOCL", "relevance_score": "0.050238", "ticker_sentiment_score": "-0.038862", "ticker_sentiment_label": "Neutral"}, {"ticker": "FTCI", "relevance_score": "0.050238", "ticker_sentiment_score": "0.005149", "ticker_sentiment_label": "Neutral"}, {"ticker": "NUZE", "relevance_score": "0.050238", "ticker_sentiment_score": "0.001988", "ticker_sentiment_label": "Neutral"}, {"ticker": "JFU", "relevance_score": "0.050238", "ticker_sentiment_score": "0.003495", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOCS", "relevance_score": "0.050238", "ticker_sentiment_score": "-0.041982", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARDS", "relevance_score": "0.075294", "ticker_sentiment_score": "-0.021001", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCVL", "relevance_score": "0.050238", "ticker_sentiment_score": "0.004879", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGTA", "relevance_score": "0.100277", "ticker_sentiment_score": "0.022299", "ticker_sentiment_label": "Neutral"}, {"ticker": "TJX", "relevance_score": "0.050238", "ticker_sentiment_score": "0.062676", "ticker_sentiment_label": "Neutral"}, {"ticker": "GBOX", "relevance_score": "0.050238", "ticker_sentiment_score": "0.108332", "ticker_sentiment_label": "Neutral"}, {"ticker": "DLTR", "relevance_score": "0.050238", "ticker_sentiment_score": "-0.32139", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MS", "relevance_score": "0.075294", "ticker_sentiment_score": "0.010118", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDL", "relevance_score": "0.075294", "ticker_sentiment_score": "0.00414", "ticker_sentiment_label": "Neutral"}, {"ticker": "KROS", "relevance_score": "0.075294", "ticker_sentiment_score": "0.006247", "ticker_sentiment_label": "Neutral"}, {"ticker": "MX", "relevance_score": "0.075294", "ticker_sentiment_score": "0.014357", "ticker_sentiment_label": "Neutral"}, {"ticker": "TOI", "relevance_score": "0.075294", "ticker_sentiment_score": "0.001805", "ticker_sentiment_label": "Neutral"}, {"ticker": "LVLU", "relevance_score": "0.050238", "ticker_sentiment_score": "0.001317", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUTO", "relevance_score": "0.075294", "ticker_sentiment_score": "-0.470526", "ticker_sentiment_label": "Bearish"}, {"ticker": "CENX", "relevance_score": "0.050238", "ticker_sentiment_score": "0.003791", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCM", "relevance_score": "0.050238", "ticker_sentiment_score": "0.002041", "ticker_sentiment_label": "Neutral"}, {"ticker": "TGI", "relevance_score": "0.050238", "ticker_sentiment_score": "-0.657635", "ticker_sentiment_label": "Bearish"}, {"ticker": "VERB", "relevance_score": "0.050238", "ticker_sentiment_score": "0.016674", "ticker_sentiment_label": "Neutral"}, {"ticker": "UNFI", "relevance_score": "0.075294", "ticker_sentiment_score": "0.008111", "ticker_sentiment_label": "Neutral"}, {"ticker": "INVO", "relevance_score": "0.075294", "ticker_sentiment_score": "-0.005484", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOWL", "relevance_score": "0.075294", "ticker_sentiment_score": "-0.000342", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMTI", "relevance_score": "0.075294", "ticker_sentiment_score": "-0.021907", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRDS", "relevance_score": "0.075294", "ticker_sentiment_score": "0.074547", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAIA", "relevance_score": "0.050238", "ticker_sentiment_score": "0.000719", "ticker_sentiment_label": "Neutral"}, {"ticker": "TGT", "relevance_score": "0.100277", "ticker_sentiment_score": "-0.581885", "ticker_sentiment_label": "Bearish"}, {"ticker": "BBIG", "relevance_score": "0.050238", "ticker_sentiment_score": "0.00332", "ticker_sentiment_label": "Neutral"}, {"ticker": "NDRA", "relevance_score": "0.075294", "ticker_sentiment_score": "-0.001784", "ticker_sentiment_label": "Neutral"}, {"ticker": "TDCX", "relevance_score": "0.075294", "ticker_sentiment_score": "0.019121", "ticker_sentiment_label": "Neutral"}, {"ticker": "AFI", "relevance_score": "0.050238", "ticker_sentiment_score": "0.006803", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCS", "relevance_score": "0.050238", "ticker_sentiment_score": "0.023986", "ticker_sentiment_label": "Neutral"}, {"ticker": "BJ", "relevance_score": "0.050238", "ticker_sentiment_score": "0.00143", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVDA", "relevance_score": "0.050238", "ticker_sentiment_score": "0.006149", "ticker_sentiment_label": "Neutral"}, {"ticker": "RKLB", "relevance_score": "0.075294", "ticker_sentiment_score": "0.010974", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROCR", "relevance_score": "0.050238", "ticker_sentiment_score": "-0.005733", "ticker_sentiment_label": "Neutral"}, {"ticker": "DPSIP", "relevance_score": "0.050238", "ticker_sentiment_score": "0.010588", "ticker_sentiment_label": "Neutral"}, {"ticker": "INT", "relevance_score": "0.050238", "ticker_sentiment_score": "0.004407", "ticker_sentiment_label": "Neutral"}, {"ticker": "DDS", "relevance_score": "0.050238", "ticker_sentiment_score": "0.002761", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOUN", "relevance_score": "0.075294", "ticker_sentiment_score": "0.01188", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENDP", "relevance_score": "0.075294", "ticker_sentiment_score": "-0.005158", "ticker_sentiment_label": "Neutral"}, {"ticker": "RMTI", "relevance_score": "0.075294", "ticker_sentiment_score": "-0.009153", "ticker_sentiment_label": "Neutral"}, {"ticker": "EOSE", "relevance_score": "0.050238", "ticker_sentiment_score": "0.003298", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASO", "relevance_score": "0.050238", "ticker_sentiment_score": "0.001415", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUUD", "relevance_score": "0.050238", "ticker_sentiment_score": "-0.01206", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIG", "relevance_score": "0.050238", "ticker_sentiment_score": "0.039709", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRBP", "relevance_score": "0.050238", "ticker_sentiment_score": "0.004643", "ticker_sentiment_label": "Neutral"}, {"ticker": "RMBL", "relevance_score": "0.050238", "ticker_sentiment_score": "-0.107561", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLVX", "relevance_score": "0.050238", "ticker_sentiment_score": "0.001149", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOOT", "relevance_score": "0.075294", "ticker_sentiment_score": "-0.019415", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIBT", "relevance_score": "0.075294", "ticker_sentiment_score": "0.05468", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIGL", "relevance_score": "0.050238", "ticker_sentiment_score": "0.00404", "ticker_sentiment_label": "Neutral"}, {"ticker": "WSM", "relevance_score": "0.050238", "ticker_sentiment_score": "0.000163", "ticker_sentiment_label": "Neutral"}, {"ticker": "OST", "relevance_score": "0.050238", "ticker_sentiment_score": "0.002469", "ticker_sentiment_label": "Neutral"}, {"ticker": "OTRA", "relevance_score": "0.075294", "ticker_sentiment_score": "0.002747", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMRS", "relevance_score": "0.050238", "ticker_sentiment_score": "-0.014718", "ticker_sentiment_label": "Neutral"}, {"ticker": "PIK", "relevance_score": "0.075294", "ticker_sentiment_score": "0.001313", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRKA", "relevance_score": "0.050238", "ticker_sentiment_score": "0.000367", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYMLF", "relevance_score": "0.025131", "ticker_sentiment_score": "0.01188", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBAI", "relevance_score": "0.075294", "ticker_sentiment_score": "-0.001109", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVNA", "relevance_score": "0.050238", "ticker_sentiment_score": "-0.002324", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLRX", "relevance_score": "0.075294", "ticker_sentiment_score": "-0.007759", "ticker_sentiment_label": "Neutral"}, {"ticker": "FFIE", "relevance_score": "0.050238", "ticker_sentiment_score": "-0.036587", "ticker_sentiment_label": "Neutral"}]}, {"title": "Proactive news headlines including Electra Battery Materials, Sonoro Gold, RespireRx Pharmaceuticals, Guardforce AI, American Manganese and Bridgeline Digital", "url": "https://www.benzinga.com/pressreleases/22/05/g27260946/proactive-news-headlines-including-electra-battery-materials-sonoro-gold-respirerx-pharmaceuticals", "time_published": "20220517T174721", "authors": ["Globe Newswire"], "summary": "New York , May 17, 2022 ( GLOBE NEWSWIRE ) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies: Bridgeline Digital says AB Commerce prescribes Celebros to treat multiple pharmacies' growth strategies c", "banner_image": "", "source": "Benzinga", "category_within_source": "Mergers", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Blockchain", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}, {"topic": "Earnings", "relevance_score": "0.413559"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}], "overall_sentiment_score": 0.031706, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "HCDI", "relevance_score": "0.042323", "ticker_sentiment_score": "0.002588", "ticker_sentiment_label": "Neutral"}, {"ticker": "KDOZF", "relevance_score": "0.042323", "ticker_sentiment_score": "0.003338", "ticker_sentiment_label": "Neutral"}, {"ticker": "RRC", "relevance_score": "0.042323", "ticker_sentiment_score": "0.007864", "ticker_sentiment_label": "Neutral"}, {"ticker": "GFAI", "relevance_score": "0.042323", "ticker_sentiment_score": "0.016787", "ticker_sentiment_label": "Neutral"}, {"ticker": "VEV", "relevance_score": "0.084527", "ticker_sentiment_score": "0.138278", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDL", "relevance_score": "0.042323", "ticker_sentiment_score": "0.005777", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYR", "relevance_score": "0.042323", "ticker_sentiment_score": "-0.001778", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLIN", "relevance_score": "0.042323", "ticker_sentiment_score": "0.025938", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELBM", "relevance_score": "0.042323", "ticker_sentiment_score": "0.007256", "ticker_sentiment_label": "Neutral"}, {"ticker": "LRTNF", "relevance_score": "0.042323", "ticker_sentiment_score": "0.082626", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLNS", "relevance_score": "0.042323", "ticker_sentiment_score": "0.011168", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCRT", "relevance_score": "0.042323", "ticker_sentiment_score": "0.012183", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSUMF", "relevance_score": "0.042323", "ticker_sentiment_score": "0.020269", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLRRF", "relevance_score": "0.042323", "ticker_sentiment_score": "0.007864", "ticker_sentiment_label": "Neutral"}, {"ticker": "VS", "relevance_score": "0.042323", "ticker_sentiment_score": "0.005113", "ticker_sentiment_label": "Neutral"}]}, {"title": "FDA Clears Cardiol Therapeutics' IND for CardiolRx in Recurrent Pericarditis", "url": "https://www.benzinga.com/general/biotech/22/05/27256756/fda-clears-cardiol-therapeutics-ind-for-cardiolrx-in-recurrent-pericarditis", "time_published": "20220517T152811", "authors": ["Ragothaman Srinivasan"], "summary": "The U.S. Food and Drug Administration ( FDA ) has cleared the Investigational New Drug Application ( IND ) from Cardiol Therapeutics Inc. ( NASDAQ: CRDL ) to start a Phase 2 open-label pilot study designed to evaluate the tolerance and safety of CardiolRx, in patients with recurrent pericardit", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/05/17/bz-pharma_2.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": -0.055325, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CRDL", "relevance_score": "0.532043", "ticker_sentiment_score": "0.005354", "ticker_sentiment_label": "Neutral"}]}, {"title": "Cardiol Therapeutics Announces FDA Investigational New Drug Application Authorization for Multicenter Phase II Open-Label Pilot Study of CardiolRx for Recurrent Pericarditis", "url": "https://investingnews.com/cardiol-therapeutics-announces-fda-investigational-new-drug-application-authorization-for-multicenter-phase-ii-open-label-pilot-study-of-cardiolrx-for-recurrent-pericarditis/", "time_published": "20220517T113505", "authors": [], "summary": "Cardiol Therapeutics Inc. ( NASDAQ: CRDL ) ( TSX: CRDL ) ( \"Cardiol\" or the \"Company\" ) , a clinical-stage life sciences company focused on the research and clinical development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease ( \"CVD\" ) , is pleased to ...", "banner_image": null, "source": "Investing News Network", "category_within_source": "n/a", "source_domain": "investingnews.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": 0.023459, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CRDL", "relevance_score": "0.099849", "ticker_sentiment_score": "0.023459", "ticker_sentiment_label": "Neutral"}]}, {"title": "68 Biggest Movers From Yesterday", "url": "https://www.benzinga.com/news/22/04/26681653/68-biggest-movers-from-yesterday", "time_published": "20220419T083535", "authors": [], "summary": "Gainers\nCasa Systems, Inc.   ( NASDAQ: CASA )  shares surged 82.5% to close at $7.10 on Monday after the company announced a multi-year contract with Verizon to provide 5G core network functions.\nEnservco Corporation  ( NASDAQ: ENSV )  climbed 38% to settle at $3.63 on Monday. Enservco delayed filin", "banner_image": "https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/04/19/yesterdays_movers.png", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.87644"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "0.95493"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.010045, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EDRY", "relevance_score": "0.057004", "ticker_sentiment_score": "0.003124", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBI", "relevance_score": "0.057004", "ticker_sentiment_score": "0.001637", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRGE", "relevance_score": "0.085416", "ticker_sentiment_score": "0.00497", "ticker_sentiment_label": "Neutral"}, {"ticker": "MULN", "relevance_score": "0.085416", "ticker_sentiment_score": "0.002821", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARQQ", "relevance_score": "0.057004", "ticker_sentiment_score": "0.000308", "ticker_sentiment_label": "Neutral"}, {"ticker": "TGTX", "relevance_score": "0.057004", "ticker_sentiment_score": "-0.0006", "ticker_sentiment_label": "Neutral"}, {"ticker": "AZYO", "relevance_score": "0.057004", "ticker_sentiment_score": "0.002612", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIRX", "relevance_score": "0.057004", "ticker_sentiment_score": "0.001993", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZVO", "relevance_score": "0.057004", "ticker_sentiment_score": "0.006272", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIXT", "relevance_score": "0.085416", "ticker_sentiment_score": "0.001798", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERU", "relevance_score": "0.057004", "ticker_sentiment_score": "0.000172", "ticker_sentiment_label": "Neutral"}, {"ticker": "VINO", "relevance_score": "0.085416", "ticker_sentiment_score": "0.002188", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYT", "relevance_score": "0.085416", "ticker_sentiment_score": "0.113743", "ticker_sentiment_label": "Neutral"}, {"ticker": "DADA", "relevance_score": "0.057004", "ticker_sentiment_score": "-0.000299", "ticker_sentiment_label": "Neutral"}, {"ticker": "STSS", "relevance_score": "0.057004", "ticker_sentiment_score": "-0.018119", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDL", "relevance_score": "0.057004", "ticker_sentiment_score": "0.002905", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDVL", "relevance_score": "0.085416", "ticker_sentiment_score": "0.000669", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTEK", "relevance_score": "0.057004", "ticker_sentiment_score": "0.001846", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYRN", "relevance_score": "0.057004", "ticker_sentiment_score": "0.003249", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPGN", "relevance_score": "0.057004", "ticker_sentiment_score": "-0.000131", "ticker_sentiment_label": "Neutral"}, {"ticker": "KAVL", "relevance_score": "0.085416", "ticker_sentiment_score": "0.009867", "ticker_sentiment_label": "Neutral"}, {"ticker": "NUTX", "relevance_score": "0.057004", "ticker_sentiment_score": "-0.000452", "ticker_sentiment_label": "Neutral"}, {"ticker": "VNCE", "relevance_score": "0.057004", "ticker_sentiment_score": "0.001285", "ticker_sentiment_label": "Neutral"}, {"ticker": "CASA", "relevance_score": "0.057004", "ticker_sentiment_score": "0.0086", "ticker_sentiment_label": "Neutral"}, {"ticker": "WORX", "relevance_score": "0.057004", "ticker_sentiment_score": "-0.001918", "ticker_sentiment_label": "Neutral"}, {"ticker": "BDSX", "relevance_score": "0.057004", "ticker_sentiment_score": "0.000381", "ticker_sentiment_label": "Neutral"}, {"ticker": "REVB", "relevance_score": "0.057004", "ticker_sentiment_score": "-0.000159", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATER", "relevance_score": "0.057004", "ticker_sentiment_score": "0.003917", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTUS", "relevance_score": "0.057004", "ticker_sentiment_score": "0.005682", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMNM", "relevance_score": "0.085416", "ticker_sentiment_score": "-0.017969", "ticker_sentiment_label": "Neutral"}, {"ticker": "VZ", "relevance_score": "0.02852", "ticker_sentiment_score": "0.0086", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLEU", "relevance_score": "0.057004", "ticker_sentiment_score": "0.001438", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADXN", "relevance_score": "0.057004", "ticker_sentiment_score": "0.007534", "ticker_sentiment_label": "Neutral"}, {"ticker": "HDB", "relevance_score": "0.057004", "ticker_sentiment_score": "-0.000882", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVDA", "relevance_score": "0.057004", "ticker_sentiment_score": "0.01666", "ticker_sentiment_label": "Neutral"}, {"ticker": "WE", "relevance_score": "0.02852", "ticker_sentiment_score": "-0.000558", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVIV", "relevance_score": "0.057004", "ticker_sentiment_score": "-0.00454", "ticker_sentiment_label": "Neutral"}, {"ticker": "GAME", "relevance_score": "0.057004", "ticker_sentiment_score": "0.003101", "ticker_sentiment_label": "Neutral"}, {"ticker": "DFFN", "relevance_score": "0.057004", "ticker_sentiment_score": "0.000411", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCRT", "relevance_score": "0.085416", "ticker_sentiment_score": "-0.000746", "ticker_sentiment_label": "Neutral"}, {"ticker": "FREQ", "relevance_score": "0.057004", "ticker_sentiment_score": "0.00114", "ticker_sentiment_label": "Neutral"}, {"ticker": "NKTR", "relevance_score": "0.113718", "ticker_sentiment_score": "0.006314", "ticker_sentiment_label": "Neutral"}, {"ticker": "GBIO", "relevance_score": "0.057004", "ticker_sentiment_score": "-0.002836", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.057004", "ticker_sentiment_score": "0.002163", "ticker_sentiment_label": "Neutral"}, {"ticker": "WRAP", "relevance_score": "0.057004", "ticker_sentiment_score": "0.00701", "ticker_sentiment_label": "Neutral"}, {"ticker": "DCFC", "relevance_score": "0.057004", "ticker_sentiment_score": "0.020699", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRSN", "relevance_score": "0.085416", "ticker_sentiment_score": "0.001752", "ticker_sentiment_label": "Neutral"}, {"ticker": "GFAI", "relevance_score": "0.057004", "ticker_sentiment_score": "0.000877", "ticker_sentiment_label": "Neutral"}, {"ticker": "HSTO", "relevance_score": "0.057004", "ticker_sentiment_score": "0.000318", "ticker_sentiment_label": "Neutral"}, {"ticker": "DIDI", "relevance_score": "0.085416", "ticker_sentiment_score": "0.002509", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCM", "relevance_score": "0.057004", "ticker_sentiment_score": "0.001358", "ticker_sentiment_label": "Neutral"}, {"ticker": "GS", "relevance_score": "0.02852", "ticker_sentiment_score": "0.006314", "ticker_sentiment_label": "Neutral"}, {"ticker": "INKT", "relevance_score": "0.057004", "ticker_sentiment_score": "0.00064", "ticker_sentiment_label": "Neutral"}, {"ticker": "USER", "relevance_score": "0.057004", "ticker_sentiment_score": "0.001322", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.02852", "ticker_sentiment_score": "0.006314", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBFM", "relevance_score": "0.057004", "ticker_sentiment_score": "-0.004451", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMRA", "relevance_score": "0.057004", "ticker_sentiment_score": "0.000897", "ticker_sentiment_label": "Neutral"}, {"ticker": "GGR", "relevance_score": "0.057004", "ticker_sentiment_score": "0.000559", "ticker_sentiment_label": "Neutral"}, {"ticker": "CELP", "relevance_score": "0.057004", "ticker_sentiment_score": "-0.005015", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCHW", "relevance_score": "0.057004", "ticker_sentiment_score": "-0.540526", "ticker_sentiment_label": "Bearish"}, {"ticker": "APCX", "relevance_score": "0.057004", "ticker_sentiment_score": "0.000291", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLBZ", "relevance_score": "0.057004", "ticker_sentiment_score": "0.000465", "ticker_sentiment_label": "Neutral"}, {"ticker": "DBGI", "relevance_score": "0.057004", "ticker_sentiment_score": "-0.06373", "ticker_sentiment_label": "Neutral"}]}, {"title": "34 Stocks Moving In Monday's Mid-Day Session", "url": "https://www.benzinga.com/news/22/04/26671086/34-stocks-moving-in-mondays-mid-day-session", "time_published": "20220418T161356", "authors": [], "summary": "Gainers\nCasa Systems, Inc.   ( NASDAQ: CASA )  shares climbed 66.3% to $6.47 after the company announced a multi-year contract with Verizon to provide 5G core network functions.\nNatus Medical Incorporated   ( NASDAQ: NTUS )  gained 28.7% to $33.53 after the company announced it will be acquired by A", "banner_image": "https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/04/18/mid-day_movers_image.jpg", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.650727"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": -0.029941, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NTUS", "relevance_score": "0.110487", "ticker_sentiment_score": "0.004275", "ticker_sentiment_label": "Neutral"}, {"ticker": "VZ", "relevance_score": "0.055377", "ticker_sentiment_score": "0.013661", "ticker_sentiment_label": "Neutral"}, {"ticker": "HDB", "relevance_score": "0.110487", "ticker_sentiment_score": "-0.00014", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRGE", "relevance_score": "0.165069", "ticker_sentiment_score": "0.002532", "ticker_sentiment_label": "Neutral"}, {"ticker": "MULN", "relevance_score": "0.165069", "ticker_sentiment_score": "0.001181", "ticker_sentiment_label": "Neutral"}, {"ticker": "WE", "relevance_score": "0.055377", "ticker_sentiment_score": "0.000707", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARQQ", "relevance_score": "0.110487", "ticker_sentiment_score": "7.3e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "TGTX", "relevance_score": "0.110487", "ticker_sentiment_score": "-0.010769", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIRX", "relevance_score": "0.110487", "ticker_sentiment_score": "0.000272", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRVI", "relevance_score": "0.110487", "ticker_sentiment_score": "0.000622", "ticker_sentiment_label": "Neutral"}, {"ticker": "HNRG", "relevance_score": "0.110487", "ticker_sentiment_score": "0.000681", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERU", "relevance_score": "0.110487", "ticker_sentiment_score": "-0.000185", "ticker_sentiment_label": "Neutral"}, {"ticker": "SJT", "relevance_score": "0.110487", "ticker_sentiment_score": "0.000616", "ticker_sentiment_label": "Neutral"}, {"ticker": "VINO", "relevance_score": "0.165069", "ticker_sentiment_score": "0.000289", "ticker_sentiment_label": "Neutral"}, {"ticker": "NKTR", "relevance_score": "0.218866", "ticker_sentiment_score": "0.001603", "ticker_sentiment_label": "Neutral"}, {"ticker": "DCFC", "relevance_score": "0.110487", "ticker_sentiment_score": "0.019639", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRSN", "relevance_score": "0.165069", "ticker_sentiment_score": "0.000478", "ticker_sentiment_label": "Neutral"}, {"ticker": "DADA", "relevance_score": "0.110487", "ticker_sentiment_score": "-0.000257", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDL", "relevance_score": "0.110487", "ticker_sentiment_score": "0.000658", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDVL", "relevance_score": "0.271636", "ticker_sentiment_score": "0.000779", "ticker_sentiment_label": "Neutral"}, {"ticker": "DIDI", "relevance_score": "0.165069", "ticker_sentiment_score": "0.001144", "ticker_sentiment_label": "Neutral"}, {"ticker": "GS", "relevance_score": "0.055377", "ticker_sentiment_score": "0.001603", "ticker_sentiment_label": "Neutral"}, {"ticker": "USER", "relevance_score": "0.110487", "ticker_sentiment_score": "-8.6e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.055377", "ticker_sentiment_score": "0.001603", "ticker_sentiment_label": "Neutral"}, {"ticker": "CASA", "relevance_score": "0.110487", "ticker_sentiment_score": "0.013661", "ticker_sentiment_label": "Neutral"}, {"ticker": "GGR", "relevance_score": "0.110487", "ticker_sentiment_score": "0.000224", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCHW", "relevance_score": "0.110487", "ticker_sentiment_score": "-0.675958", "ticker_sentiment_label": "Bearish"}, {"ticker": "APCX", "relevance_score": "0.110487", "ticker_sentiment_score": "-0.002813", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLBZ", "relevance_score": "0.110487", "ticker_sentiment_score": "-0.000122", "ticker_sentiment_label": "Neutral"}]}, {"title": "51 Biggest Movers From Thursday", "url": "https://www.benzinga.com/news/22/04/26660206/51-biggest-movers-from-thursday", "time_published": "20220418T092156", "authors": [], "summary": "Gainers\nMedAvail Holdings, Inc.  ( NASDAQ: MDVL )  shares surged 69.4% to close at $2.44 on Thursday. Ally Bridge Group recently reported a purchase of 21.176 million shares of MedAvail Holdings for an average price of $1.06 per share.\nIndonesia Energy Corporation Limited  ( NYSE: INDO )  gained 65.", "banner_image": "https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/04/18/yesterdays_movers.png", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "IPO", "relevance_score": "0.310843"}, {"topic": "Financial Markets", "relevance_score": "0.977154"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.538269"}, {"topic": "Real Estate & Construction", "relevance_score": "0.2"}], "overall_sentiment_score": -0.008156, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "RERE", "relevance_score": "0.069495", "ticker_sentiment_score": "-0.009222", "ticker_sentiment_label": "Neutral"}, {"ticker": "CXW", "relevance_score": "0.069495", "ticker_sentiment_score": "0.006683", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMPP", "relevance_score": "0.069495", "ticker_sentiment_score": "0.004891", "ticker_sentiment_label": "Neutral"}, {"ticker": "INZY", "relevance_score": "0.069495", "ticker_sentiment_score": "0.002125", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNR", "relevance_score": "0.069495", "ticker_sentiment_score": "0.000385", "ticker_sentiment_label": "Neutral"}, {"ticker": "SISI", "relevance_score": "0.104078", "ticker_sentiment_score": "0.002285", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRGE", "relevance_score": "0.069495", "ticker_sentiment_score": "0.002226", "ticker_sentiment_label": "Neutral"}, {"ticker": "PHAS", "relevance_score": "0.069495", "ticker_sentiment_score": "0.003169", "ticker_sentiment_label": "Neutral"}, {"ticker": "AREB", "relevance_score": "0.069495", "ticker_sentiment_score": "0.000599", "ticker_sentiment_label": "Neutral"}, {"ticker": "GMBL", "relevance_score": "0.069495", "ticker_sentiment_score": "-0.179891", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AMST", "relevance_score": "0.069495", "ticker_sentiment_score": "0.004151", "ticker_sentiment_label": "Neutral"}, {"ticker": "RENN", "relevance_score": "0.104078", "ticker_sentiment_score": "0.005536", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRVI", "relevance_score": "0.104078", "ticker_sentiment_score": "0.001156", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEGG", "relevance_score": "0.03478", "ticker_sentiment_score": "0.001193", "ticker_sentiment_label": "Neutral"}, {"ticker": "LEXX", "relevance_score": "0.069495", "ticker_sentiment_score": "0.016523", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIXT", "relevance_score": "0.104078", "ticker_sentiment_score": "0.002709", "ticker_sentiment_label": "Neutral"}, {"ticker": "MARPS", "relevance_score": "0.069495", "ticker_sentiment_score": "0.002277", "ticker_sentiment_label": "Neutral"}, {"ticker": "REDU", "relevance_score": "0.069495", "ticker_sentiment_score": "0.000271", "ticker_sentiment_label": "Neutral"}, {"ticker": "IO", "relevance_score": "0.069495", "ticker_sentiment_score": "-0.01962", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDL", "relevance_score": "0.069495", "ticker_sentiment_score": "0.003731", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDVL", "relevance_score": "0.104078", "ticker_sentiment_score": "0.002027", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMBM", "relevance_score": "0.069495", "ticker_sentiment_score": "0.00304", "ticker_sentiment_label": "Neutral"}, {"ticker": "AYLA", "relevance_score": "0.069495", "ticker_sentiment_score": "0.005009", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRXT", "relevance_score": "0.069495", "ticker_sentiment_score": "0.002947", "ticker_sentiment_label": "Neutral"}, {"ticker": "WORX", "relevance_score": "0.069495", "ticker_sentiment_score": "0.008007", "ticker_sentiment_label": "Neutral"}, {"ticker": "RVSN", "relevance_score": "0.069495", "ticker_sentiment_score": "0.0022", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZY", "relevance_score": "0.069495", "ticker_sentiment_score": "0.000805", "ticker_sentiment_label": "Neutral"}, {"ticker": "TANH", "relevance_score": "0.069495", "ticker_sentiment_score": "0.001258", "ticker_sentiment_label": "Neutral"}, {"ticker": "AIRG", "relevance_score": "0.069495", "ticker_sentiment_score": "0.009842", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLAR", "relevance_score": "0.03478", "ticker_sentiment_score": "0.002947", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLRB", "relevance_score": "0.104078", "ticker_sentiment_score": "0.01947", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGLY", "relevance_score": "0.069495", "ticker_sentiment_score": "0.001109", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTGX", "relevance_score": "0.069495", "ticker_sentiment_score": "-0.009024", "ticker_sentiment_label": "Neutral"}, {"ticker": "QCOM", "relevance_score": "0.069495", "ticker_sentiment_score": "0.009192", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEXT", "relevance_score": "0.069495", "ticker_sentiment_score": "0.001572", "ticker_sentiment_label": "Neutral"}, {"ticker": "CISO", "relevance_score": "0.069495", "ticker_sentiment_score": "0.001036", "ticker_sentiment_label": "Neutral"}, {"ticker": "VSTM", "relevance_score": "0.069495", "ticker_sentiment_score": "0.006287", "ticker_sentiment_label": "Neutral"}, {"ticker": "LYRA", "relevance_score": "0.069495", "ticker_sentiment_score": "0.003235", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.069495", "ticker_sentiment_score": "0.000993", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFRI", "relevance_score": "0.104078", "ticker_sentiment_score": "0.007446", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISO", "relevance_score": "0.069495", "ticker_sentiment_score": "0.001345", "ticker_sentiment_label": "Neutral"}, {"ticker": "GFAI", "relevance_score": "0.104078", "ticker_sentiment_score": "0.002048", "ticker_sentiment_label": "Neutral"}, {"ticker": "HSTO", "relevance_score": "0.069495", "ticker_sentiment_score": "-1.8e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLSE", "relevance_score": "0.03478", "ticker_sentiment_score": "-0.179891", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BRQS", "relevance_score": "0.069495", "ticker_sentiment_score": "0.009192", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMLS", "relevance_score": "0.069495", "ticker_sentiment_score": "0.004472", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVOL", "relevance_score": "0.069495", "ticker_sentiment_score": "-0.075334", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBFM", "relevance_score": "0.069495", "ticker_sentiment_score": "0.000545", "ticker_sentiment_label": "Neutral"}, {"ticker": "SYTA", "relevance_score": "0.069495", "ticker_sentiment_score": "0.001243", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARTL", "relevance_score": "0.104078", "ticker_sentiment_score": "0.002026", "ticker_sentiment_label": "Neutral"}, {"ticker": "APCX", "relevance_score": "0.069495", "ticker_sentiment_score": "0.003281", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:NANO", "relevance_score": "0.03478", "ticker_sentiment_score": "0.002277", "ticker_sentiment_label": "Neutral"}]}, {"title": "Proactive news headlines including Nevada Silver, Contakt World, SPYR Technologies, Gamesquare Esports, Bloom Health Partners and Predictive Oncology", "url": "https://www.benzinga.com/pressreleases/22/03/g26286957/proactive-news-headlines-including-nevada-silver-contakt-world-spyr-technologies-gamesquare-esport", "time_published": "20220324T185530", "authors": ["Globe Newswire"], "summary": "New York , March  24, 2022   ( GLOBE NEWSWIRE )  -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies:\nNevada Silver provides update on Emily Manganese project and Belmont silver property purchase click her", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "Mergers", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}, {"topic": "Blockchain", "relevance_score": "0.310843"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}, {"topic": "Earnings", "relevance_score": "0.538269"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}], "overall_sentiment_score": 0.018729, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BELMF", "relevance_score": "0.050992", "ticker_sentiment_score": "0.003192", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLIN", "relevance_score": "0.050992", "ticker_sentiment_score": "0.021691", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLK", "relevance_score": "0.050992", "ticker_sentiment_score": "-0.076354", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCDI", "relevance_score": "0.050992", "ticker_sentiment_score": "0.222355", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "POAI", "relevance_score": "0.050992", "ticker_sentiment_score": "0.00692", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRFXF", "relevance_score": "0.050992", "ticker_sentiment_score": "-0.128794", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDL", "relevance_score": "0.050992", "ticker_sentiment_score": "0.188591", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BLVDF", "relevance_score": "0.050992", "ticker_sentiment_score": "0.000908", "ticker_sentiment_label": "Neutral"}, {"ticker": "PALT", "relevance_score": "0.050992", "ticker_sentiment_score": "0.000546", "ticker_sentiment_label": "Neutral"}, {"ticker": "UTOLF", "relevance_score": "0.050992", "ticker_sentiment_score": "0.027968", "ticker_sentiment_label": "Neutral"}]}, {"title": "Cardiol Therapeutics Announces Year-End 2021 Update on Operations", "url": "https://investingnews.com/cardiol-therapeutics-announces-year-end-2021-update-on-operations/", "time_published": "20220324T120938", "authors": [], "summary": "Cardiol Therapeutics Inc.  (  NASDAQ: CRDL  )   (  TSX: CRDL  )   (  \"Cardiol\" or the \"Company\"  )  , a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease  (  \"CVD\"  )  , today announces its year-end 2021 update on operations following the filing of its audited Financial Statements and Management's Discussion and Analysis for the year ended December 31, 2021. Both are available under the Company's profile on SEDAR at sedar.com and on the Company's website at cardiolrx.com.", "banner_image": "https://investingnews.com/media-library/image.jpg?id=27866453&width=1200&coordinates=0%2C42%2C0%2C42&height=600", "source": "Investing News Network", "category_within_source": "n/a", "source_domain": "investingnews.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": 0.0744, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CRDL", "relevance_score": "0.27476", "ticker_sentiment_score": "0.0744", "ticker_sentiment_label": "Neutral"}]}, {"title": "Cardiol Therapeutics to Participate in Cantor Fitzgerald's Virtual Rare Orphan Disease Summit", "url": "https://investingnews.com/cardiol-therapeutics-to-participate-in-cantor-fitzgerald-s-virtual-rare-orphan-disease-summit/", "time_published": "20220322T115005", "authors": [], "summary": "Cardiol Therapeutics Inc.  (  NASDAQ: CRDL  )   (  TSX: CRDL  )   (  \"Cardiol\" or the \"Company\"  )  , a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease, announced today that Cardiol's Chief Medical Officer, Dr. Andrew Hamer, will be participating in a panel discussion entitled \"New World Order for EndoCVRenal Disease\" at Cantor Fitzgerald's Virtual Rare Orphan Disease Summit on Tuesday, March 29th, at 1:00 p.m. EDT.", "banner_image": "https://investingnews.com/media-library/image.jpg?id=27866453&width=1200&coordinates=0%2C42%2C0%2C42&height=600", "source": "Investing News Network", "category_within_source": "n/a", "source_domain": "investingnews.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": 0.005834, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CRDL", "relevance_score": "0.271395", "ticker_sentiment_score": "0.005834", "ticker_sentiment_label": "Neutral"}]}, {"title": "Proactive news headlines including Walt Disney, Zeb Nickel, CLS Holdings, Trees Corporation, Plurilock Security and Adastra Holdings", "url": "https://www.benzinga.com/pressreleases/22/03/g26152113/proactive-news-headlines-including-walt-disney-zeb-nickel-cls-holdings-trees-corporation-plurilock", "time_published": "20220315T182825", "authors": ["Globe Newswire"], "summary": "New York , March  15, 2022   ( GLOBE NEWSWIRE )  -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies: \nEx Walt Disney boss Bob Iger invests in metaverse start-up Genies click here\nNorthstar Gold says last ", "banner_image": "https://premium-newsletters-wp-cdn.benzinga.com/uploads/2022/03/11174002/Screenshot_54.jpg", "source": "Benzinga", "category_within_source": "Mergers", "source_domain": "www.benzinga.com", "topics": [{"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.929393"}, {"topic": "Manufacturing", "relevance_score": "0.5"}], "overall_sentiment_score": -0.039085, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MKVNF", "relevance_score": "0.045989", "ticker_sentiment_score": "0.022869", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRBLF", "relevance_score": "0.045989", "ticker_sentiment_score": "0.003681", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENVB", "relevance_score": "0.045989", "ticker_sentiment_score": "0.001629", "ticker_sentiment_label": "Neutral"}, {"ticker": "XTXXF", "relevance_score": "0.045989", "ticker_sentiment_score": "0.01886", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDL", "relevance_score": "0.045989", "ticker_sentiment_score": "0.029048", "ticker_sentiment_label": "Neutral"}, {"ticker": "DIS", "relevance_score": "0.045989", "ticker_sentiment_score": "0.018453", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRLVF", "relevance_score": "0.045989", "ticker_sentiment_score": "0.016939", "ticker_sentiment_label": "Neutral"}]}, {"title": "Cardiol Therapeutics Appoints Jennifer M. Chao to Its Board of Directors", "url": "https://investingnews.com/cardiol-therapeutics-appoints-jennifer-m-chao-to-its-board-of-directors/", "time_published": "20220315T114529", "authors": [], "summary": "Cardiol Therapeutics Inc.  (  NASDAQ: CRDL  )   (  TSX: CRDL  )   (  \"Cardiol\" or the \"Company\"  )  , a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease  (  \"CVD\"  )  , is pleased to announce that its Board of Directors has appointed Jennifer M. Chao to serve as a director, effective immediately. Ms. Chao has also been appointed Chair of the Corporate Governance and Compensation Committee.", "banner_image": "https://investingnews.com/media-library/image.jpg?id=27866453&width=1200&coordinates=0%2C42%2C0%2C42&height=600", "source": "Investing News Network", "category_within_source": "n/a", "source_domain": "investingnews.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.191493, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CRDL", "relevance_score": "0.216376", "ticker_sentiment_score": "0.28787", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Stocks That Hit 52-Week Lows On Friday", "url": "https://www.benzinga.com/news/22/03/26102456/stocks-that-hit-52-week-lows-on-friday", "time_published": "20220311T173551", "authors": [], "summary": "During Friday's session, 198 companies made new 52-week lows.\nKey Facts About Today's 52-Week Highs And Lows:\nAlibaba Group Holding  ( NYSE:BABA )  is the largest company in terms of market cap to set a new 52-week low this morning.\nThe smallest company by market cap to set a new 52-week low was Hap", "banner_image": "https://cdn.benzinga.com/files/imagecache/story_image_685x375C/images/story/2022/movers_image_4149.jpeg", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.014035, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ZUMZ", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.014415", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNTB", "relevance_score": "0.011663", "ticker_sentiment_score": "0.001319", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIDU", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.003074", "ticker_sentiment_label": "Neutral"}, {"ticker": "TIGR", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.002063", "ticker_sentiment_label": "Neutral"}, {"ticker": "LFC", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.007844", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIVN", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.001352", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOCO", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.001464", "ticker_sentiment_label": "Neutral"}, {"ticker": "XNET", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.01026", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCTZF", "relevance_score": "0.011663", "ticker_sentiment_score": "0.007962", "ticker_sentiment_label": "Neutral"}, {"ticker": "CAAS", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.022656", "ticker_sentiment_label": "Neutral"}, {"ticker": "ODC", "relevance_score": "0.011663", "ticker_sentiment_score": "0.005977", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTNT", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.023048", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANIK", "relevance_score": "0.011663", "ticker_sentiment_score": "-4e-06", "ticker_sentiment_label": "Neutral"}, {"ticker": "COMM", "relevance_score": "0.011663", "ticker_sentiment_score": "0.001588", "ticker_sentiment_label": "Neutral"}, {"ticker": "QD", "relevance_score": "0.011663", "ticker_sentiment_score": "0.00159", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXDX", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.001076", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMSI", "relevance_score": "0.011663", "ticker_sentiment_score": "0.000659", "ticker_sentiment_label": "Neutral"}, {"ticker": "GDS", "relevance_score": "0.011663", "ticker_sentiment_score": "0.002573", "ticker_sentiment_label": "Neutral"}, {"ticker": "QH", "relevance_score": "0.011663", "ticker_sentiment_score": "0.003231", "ticker_sentiment_label": "Neutral"}, {"ticker": "WDC", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.28657", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "XMTR", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.001196", "ticker_sentiment_label": "Neutral"}, {"ticker": "BILI", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.000853", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOCU", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.00899", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMWL", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.403253", "ticker_sentiment_label": "Bearish"}, {"ticker": "YY", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.005645", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDL", "relevance_score": "0.011663", "ticker_sentiment_score": "0.002562", "ticker_sentiment_label": "Neutral"}, {"ticker": "IQ", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.001444", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAND", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.007349", "ticker_sentiment_label": "Neutral"}, {"ticker": "NODK", "relevance_score": "0.023323", "ticker_sentiment_score": "0.199741", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ZH", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.004664", "ticker_sentiment_label": "Neutral"}, {"ticker": "UXIN", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.001979", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACLX", "relevance_score": "0.011663", "ticker_sentiment_score": "0.001524", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCOR", "relevance_score": "0.011663", "ticker_sentiment_score": "0.008558", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZM", "relevance_score": "0.011663", "ticker_sentiment_score": "4.9e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "KIRK", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.014511", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRTO", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.002408", "ticker_sentiment_label": "Neutral"}, {"ticker": "WLDN", "relevance_score": "0.011663", "ticker_sentiment_score": "0.003178", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLYYY", "relevance_score": "0.011663", "ticker_sentiment_score": "0.148593", "ticker_sentiment_label": "Neutral"}, {"ticker": "HTHT", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.002623", "ticker_sentiment_label": "Neutral"}, {"ticker": "IAS", "relevance_score": "0.011663", "ticker_sentiment_score": "0.001858", "ticker_sentiment_label": "Neutral"}, {"ticker": "JD", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.000845", "ticker_sentiment_label": "Neutral"}, {"ticker": "ICLK", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.01088", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLI", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.016681", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLK", "relevance_score": "0.058264", "ticker_sentiment_score": "0.003832", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPFI", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.000667", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIDU", "relevance_score": "0.011663", "ticker_sentiment_score": "0.005537", "ticker_sentiment_label": "Neutral"}, {"ticker": "TXG", "relevance_score": "0.011663", "ticker_sentiment_score": "0.005136", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZEPP", "relevance_score": "0.011663", "ticker_sentiment_score": "0.001261", "ticker_sentiment_label": "Neutral"}, {"ticker": "C", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.025575", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBLA", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.262474", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TPB", "relevance_score": "0.011663", "ticker_sentiment_score": "0.033006", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMCM", "relevance_score": "0.011663", "ticker_sentiment_score": "0.002506", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCAT", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.274499", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SEMR", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.00011", "ticker_sentiment_label": "Neutral"}, {"ticker": "BYND", "relevance_score": "0.011663", "ticker_sentiment_score": "2.9e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "AOUT", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.398054", "ticker_sentiment_label": "Bearish"}, {"ticker": "YALA", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.281462", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ZTO", "relevance_score": "0.011663", "ticker_sentiment_score": "0.003588", "ticker_sentiment_label": "Neutral"}, {"ticker": "BZ", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.017", "ticker_sentiment_label": "Neutral"}, {"ticker": "TDOC", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.001663", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVLR", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.000733", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATHM", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.007878", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMAB", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.001652", "ticker_sentiment_label": "Neutral"}, {"ticker": "YSG", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.005622", "ticker_sentiment_label": "Neutral"}, {"ticker": "TUYA", "relevance_score": "0.011663", "ticker_sentiment_score": "0.005432", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTRN", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.025575", "ticker_sentiment_label": "Neutral"}, {"ticker": "TAL", "relevance_score": "0.011663", "ticker_sentiment_score": "0.0165", "ticker_sentiment_label": "Neutral"}, {"ticker": "SQNS", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.00024", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATY", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.005182", "ticker_sentiment_label": "Neutral"}, {"ticker": "RAAS", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.000934", "ticker_sentiment_label": "Neutral"}, {"ticker": "HBB", "relevance_score": "0.011663", "ticker_sentiment_score": "0.004625", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNG", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.003908", "ticker_sentiment_label": "Neutral"}, {"ticker": "LX", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.005451", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOAH", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.00932", "ticker_sentiment_label": "Neutral"}, {"ticker": "LZ", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.003702", "ticker_sentiment_label": "Neutral"}, {"ticker": "FTCH", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.01664", "ticker_sentiment_label": "Neutral"}, {"ticker": "IDN", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.001059", "ticker_sentiment_label": "Neutral"}, {"ticker": "MLR", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.007296", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADAG", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.011698", "ticker_sentiment_label": "Neutral"}, {"ticker": "HAPP", "relevance_score": "0.023323", "ticker_sentiment_score": "0.129727", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTNB", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.002048", "ticker_sentiment_label": "Neutral"}, {"ticker": "YUMC", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.009174", "ticker_sentiment_label": "Neutral"}, {"ticker": "BABA", "relevance_score": "0.023323", "ticker_sentiment_score": "0.011716", "ticker_sentiment_label": "Neutral"}, {"ticker": "OSUR", "relevance_score": "0.011663", "ticker_sentiment_score": "0.009765", "ticker_sentiment_label": "Neutral"}, {"ticker": "GSMG", "relevance_score": "0.011663", "ticker_sentiment_score": "0.148593", "ticker_sentiment_label": "Neutral"}, {"ticker": "EM", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.002501", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCOM", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.052588", "ticker_sentiment_label": "Neutral"}, {"ticker": "WEAV", "relevance_score": "0.011663", "ticker_sentiment_score": "0.001254", "ticker_sentiment_label": "Neutral"}, {"ticker": "FTRP", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.001484", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSP", "relevance_score": "0.011663", "ticker_sentiment_score": "0.003943", "ticker_sentiment_label": "Neutral"}, {"ticker": "FUTU", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.020682", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCP", "relevance_score": "0.011663", "ticker_sentiment_score": "0.012648", "ticker_sentiment_label": "Neutral"}, {"ticker": "TLYS", "relevance_score": "0.011663", "ticker_sentiment_score": "0.037655", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTWN", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.002048", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVC", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.009988", "ticker_sentiment_label": "Neutral"}, {"ticker": "YMM", "relevance_score": "0.011663", "ticker_sentiment_score": "-4.2e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "DAKT", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.007639", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVO", "relevance_score": "0.011663", "ticker_sentiment_score": "0.002297", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAM", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.005279", "ticker_sentiment_label": "Neutral"}, {"ticker": "LTH", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.000463", "ticker_sentiment_label": "Neutral"}, {"ticker": "BEKE", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.006797", "ticker_sentiment_label": "Neutral"}, {"ticker": "VAXX", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.025676", "ticker_sentiment_label": "Neutral"}, {"ticker": "WIMI", "relevance_score": "0.011663", "ticker_sentiment_score": "0.000336", "ticker_sentiment_label": "Neutral"}, {"ticker": "COCO", "relevance_score": "0.011663", "ticker_sentiment_score": "0.003254", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOYU", "relevance_score": "0.011663", "ticker_sentiment_score": "0.001789", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNSE", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.004427", "ticker_sentiment_label": "Neutral"}, {"ticker": "WB", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.311696", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "IVZ", "relevance_score": "0.034979", "ticker_sentiment_score": "0.005206", "ticker_sentiment_label": "Neutral"}, {"ticker": "LVOX", "relevance_score": "0.011663", "ticker_sentiment_score": "0.001628", "ticker_sentiment_label": "Neutral"}, {"ticker": "RPAY", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.363536", "ticker_sentiment_label": "Bearish"}, {"ticker": "PDD", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.000385", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLXP", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.036389", "ticker_sentiment_label": "Neutral"}, {"ticker": "GAME", "relevance_score": "0.011663", "ticker_sentiment_score": "0.023745", "ticker_sentiment_label": "Neutral"}, {"ticker": "ECOM", "relevance_score": "0.011663", "ticker_sentiment_score": "0.001232", "ticker_sentiment_label": "Neutral"}, {"ticker": "HUIZ", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.010869", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBLN", "relevance_score": "0.011663", "ticker_sentiment_score": "0.001723", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIPS", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.001059", "ticker_sentiment_label": "Neutral"}, {"ticker": "QFIN", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.004839", "ticker_sentiment_label": "Neutral"}, {"ticker": "KBAL", "relevance_score": "0.011663", "ticker_sentiment_score": "0.002762", "ticker_sentiment_label": "Neutral"}, {"ticker": "APLT", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.000582", "ticker_sentiment_label": "Neutral"}, {"ticker": "DIDI", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.193429", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BZUN", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.002808", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIOT", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.01195", "ticker_sentiment_label": "Neutral"}, {"ticker": "WVFC", "relevance_score": "0.011663", "ticker_sentiment_score": "0.001195", "ticker_sentiment_label": "Neutral"}, {"ticker": "NIO", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.044474", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPRA", "relevance_score": "0.011663", "ticker_sentiment_score": "-0.021923", "ticker_sentiment_label": "Neutral"}, {"ticker": "IPA", "relevance_score": "0.011663", "ticker_sentiment_score": "0.010872", "ticker_sentiment_label": "Neutral"}]}]}